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ABSTRACT
Hypoplastic left heart syndrome (HLHS) is a type of heart defect where the left ventricle
is underdeveloped or not developed, resulting in only a single functioning right ventricle.
Approximately 7.5% of patients with congenital heart disease are born with a single ventricle (SV)
which is accompanied by a spectrum of other malformations such as atrophied ascending aorta,
atrial septal defects, and ventricular septal defects (VSD).
The existing three-hybrid staged surgical approach serving as a palliative treatment for this
anomaly entails multiple complications and achieves a survival rate of only 50%. To reduce the
trauma associated with the second stage of the hybrid procedure the hybrid comprehensive stage
2 (HCSII) operation can be a novel palliation alternative for a select subset of SV patients with
adequate antegrade aortic flow. The procedure reduces surgical trauma in newborns by introducing
a stented intrapulmonary baffle to avoid dissection of the pulmonary arteries and reconstruction of
the aortic arch while obviating the dissection of the ductal continuation and distal arch.
It is the purpose of this dissertation to undertake a computational investigation to elucidate
the complex hemodynamics of patients who have undergone HCS II. This was accomplished in a
multiscale manner coupling a 0D lumped parameter model (LPM) of the peripheral circulation
with 3D pulsatile Computational Fluid Dynamics (CFD) model providing the details and enabling
investigation of the HCS II complex hemodynamics. The use of CFD allows modeling of blood
flow, the study of the effect of different surgical procedures, suggestion of potential improvements
from investigation of areas of concern which are: the pressure drop across the baffle, the loading
of the baffle itself, shear stress and shear rates that might lead to thrombus formation, as well as
oxygen transport and particle residence time.
A 3D anatomical model representative of a patient having undergone the HCSII was
rendered utilizing the solid modeling software Solidworks based on anatomical landmarks from
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CT scans, and a 0D LPM was tuned to produce flowrates and waveforms that matched catheter
data. The pulsatile CFD computations were carried out using the commercial STARCCM+ solver.
Several cases of baffle strictures relevant to surgical implementations were considered and results
showed that the largest pressure drop across the baffle reported was about 3 mmHg while for the
same narrowing size and accounting for the distal arch kink, a four-fold increase is observed
yielding a 12.15 mmHg drop. Moreover, the analysis showed that for averaged blood flow velocity
of 0.5 m/s, no vortex shedding from the baffle was observed in the computational model due to
the short distance from the baffle to the aortic arch apex.
The velocity and pressure-flow fields were examined at different points throughout the
cardia cycle: late diastole, early systole, peak systole, and early diastole. Reverse flow was
observed towards late diastolic phase due to the presence of an adverse pressure gradient, and a
stagnant flow in the aortic arch apex was also noticed. For the pulmonary circulation and due to
the low flow velocity and low pulsatility, the T-junction shape of the SVC presented no risk of
recirculation or swirling that may promote thrombogenesis.
The wall shear stress on the baffle surface was also reported in pulsatile flow. It was
observed that the flow detaches in systole and subsequently reattaches to the baffle surface.
Moreover, the baffle surface experiences high wall shear stress magnitudes during systole and
uneven distribution of WSS during diastole.
The variation in the baffle related narrowing had a little impact on the flow hemodynamics,
as shown by the nearly constant oxygen transport across the models. The geometrical modification
applied to the models had little effect on the oxygen delivery for up to a 15% change between a 4
mm increment of MPA minimum diameter. The results showed consistency with the published
data of Glenn patients. Particle residence time was also reported to identify any blood recirculation
or flow stagnation that may lead to platelet activation leading to clot formation rate .On average
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particles take about 0.5(s) to exit the fluid domain. This time span is equal to the time of one
cardiac cycle. Finally, the energy loss and energy efficiency were calculated as a function of split
ratio and baffle related narrowing. Across all models, the efficiency was shown to be high.
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CHAPTER ONE:
INTRODUCTION
1.1 Normal Heart Anatomy
Humans have a very complicated cardiovascular system that consists of the heart and a
closed system of vessels (arteries, veins, and capillaries). The heart consists of two parts left and
right, four chambers and four valves. The atrial and ventricular septum separates the left and right
parts of the heart, and both consist of upper and lower chambers. The upper two chambers are the
left and right atriums, and the lower two chambers are the left and right ventricles. The right atrium
receives the deoxygenated blood from the upper circulation through the superior vena cava and
from the lower body circulation through the inferior vena cava. Then the poor-oxygen blood flows
down to the right ventricle through the tricuspid valve.
A healthy human has two blood circulations: the systemic circulation and the pulmonary
circulation. The systemic is responsible for supplying the blood and nutrients to the organs and all
the vessels and the capillaries where the exchange happens. The pulmonary circulation vessels
carry the deoxygenated blood from the right ventricle to the lungs to be oxygenated. Then, the
pulmonary veins transport the oxygen-rich blood back to the left atrium as shown in Figure 1.
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Figure 1 Human Circulatory System[1]
The pulmonary circulation starts when the pulmonary valve, which controls the blood flow
between the right ventricle and the lungs, opens and the right ventricle walls contract to pump the
depleted blood to the left and right lungs through the pulmonary arteries. The lungs job is to pass
oxygen into the blood and get rid of any waste like carbon dioxide. The oxygenated blood, then,
flows back to the heart, specifically to the left atrium, and through the mitral valve, the blood
passes into the left ventricle. The left ventricle walls are thicker and more developed than the right
ventricles to allow the ventricle to pump high-pressure blood to the systemic circulation through
the aortic valve. The heart muscles are provided with blood through small vessels named the
2

coronaries. The coronaries receive blood from the ascending aorta root and consist of two branches
right and left coronary arteries.

1.2 Hypoplastic Left Heart Syndrome (HLHS)
Hypoplastic left heart syndrome (HLHS) is a congenital heart defect where patients are
born with underdeveloped or not developed left ventricle resulting in only a single functioning
right ventricle. Approximately 2-9% of patients with congenital heart disease are born with a single
ventricle (SV), and it accounts for 23% of cardiac death that occurs in the early days after birth[2].
Moreover, yearly, about 640 to 1440 neonates are born with a single ventricle in the United
States[3]. Furthermore, HLHS occurs mainly in men (55% to 70 %)[4].The inherited genes might
be the reason for this disease, but researchers have not yet fully understood the genetic causes.
Turner syndrome, Holt-Oram syndrome, Smith-Lemli-Opitz syndrome, Noonan syndrome,
trisomy 13, etc. are examples of genetic disorders associated with this defect [4-7]. HLHS is
usually accompanied by a spectrum of other malformations such as the atrophied ascending aorta,
atrial septal defects (ASD), and atresia of the mitral and aortic valves and that means no ejection
from the left ventricle to the systemic circulation. A surgical intervention is required to restore the
heart function by making the right ventricle the main pump for both the systemic and the
pulmonary circulation in order to save the lives of these patients. Usually, the patent ductus
arteriosus (PDA) is open after birth for patients with a single ventricle. The PDA is a hole that
allows the blood to bypass the lungs and flow directly to the body since the blood is oxygenated
at the placenta, and it closes during the first few days of life, and that will lead to death in patients
with single ventricle. The Atrial septal defect (ASD) is a hole in the wall the separates the two
upper chambers of the heart. This opening allows the blood to flow from the lungs to the heart.
Now, both the oxygenated and the deoxygenated blood are mixed up in the right atrium, and the
3

right ventricle is responsible for pumping blood to both the systemic circulation and the pulmonary
circulation. The survival rate was about 5% during the first month of life before 1980 [8-10]. There
are two options to treat patients with a single ventricle: heart transplant or staged surgical
procedures. The heart transplant is limited due to the lack of donors, and many infants die waiting
for a donor [8, 11, 12]. One study found that the waiting time for the right donor ranges between
zero to 100 days. Moreover, the management during the waiting period could be challenging[9].
The survival rate was reported to be 48% after two years and 47% after three years and the major
cause of death is a rejection of the transplant [13-15]. The second option is more common, and it
consists of a three staged operations. The main goal of the palliative open-heart surgeries is to
achieve a functional serial circulation driven by the single functioning right ventricle.

Figure 2 Anatomy of Normal Human Heart (Left) versus Hypoplastic Left Heart Syndrome
Heart (Right)[16]
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1.2.1

Surgical Stage 1

Stage 1 (Norwood procedure) was named after William Norwood, who developed this
surgery in 1979 at Boston children’s Hospital. This procedure takes place right after birth, and the
main goal of the Norwood procedure is to make the right ventricle the main pump. This surgical
procedure consists of: (1) dissect the pulmonary arteries (PAs) of the pulmonary trunk and patched,
(2) connect the right ventricle and the aorta and that can be done by reconstructing the aorta using
the main pulmonary artery to generate a new aorta, (3) place a shunt between the innominate artery
and the PAs to provide blood flow to the lungs, (4) enlarge the atrial septum to allow oxygenated
blood to return to the right atrium. After the operation, the right ventricle is now pumping the
mixed blood through the constructed aorta to the systemic circulation, and part of the flow will be
flowing to the lungs through the shunt. Furthermore, the heart now is carrying a higher load than
usual because it must pumps more blood than usual, and the arterial oxygen saturation ranges
between 75-85%[2] due to the mixing in blood between the poor and rich oxygen in the atrium.

Figure 3 Norwood Procedure (Left) the procedure with a systemic pulmonary artery shunt
(Blalock-Taussig), (Right) a shunt between the right ventricle–pulmonary artery[17]
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The first shunt was used by Blalock and Taussig in 1945 and named Blalock Taussig (BT)
shunt[18]. The BT shunt is a connection between the transected subclavian artery or the innominate
artery and the pulmonary artery. The BT shunt has a long operation time, and it required the
sacrifices of an artery(subclavian artery or the innominate)[19]. A synthetic shunt named, a
modified BT shunt (MBTs) was introduced to between the innominate artery and pulmonary
arteries. The shunt diameter is 3.5 or 4.0 mm, depending on the patient's size [2]. Sano shunt is
considered an alternative to the MBTs where a shunt is placed between the right ventricle and a
pulmonary artery, and it works as the source for the pulmonary flow[20].

1.2.2

Surgical Stage 2

The second stage is known as Bidirectional Glenn, and it takes place around 6-8 months of
age when the pulmonary vascular resistance has dropped. The main goal of this transitional
procedure is to reduce the load on the right ventricle and provide stabled low-pressure pulmonary
flow. Glenn procedure consists of (1) removing the MBTs shunt, (2) dissection of the superior
vena cava from the right atrium and anastomosed to the right pulmonary artery to provide venous
return to the lungs and to prevent any mix in the atrium between the deoxygenated blood coming
from the upper body and the oxygen-rich blood coming from the lungs.
Surgeons have two options to establish a source of pulmonary flow - the bidirectional
Glenn (BDG) and the Hemi-Fontan procedure (HFP). The BDG is a straightforward operation
where the SVC is detached from the right atrium and connected directly to the pulmonary arteries.
The HFP does not require extensive dissection around the SVC, which may lead to phrenic nerve
injury, it provides better hemodynamics performance than the BDG and less mortality and
morbidity, but it is more complicated than the BDG and may lead to arrhythmias [21, 22]. In this
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operation, a patch is placed at the end of the superior vena cava to prevent the depleted blood from
entering the right atrium. Moreover, two incisions are made by a surgeon: the first one is at the top
of the right atrium, and the second incision takes place at the pulmonary arteries posterior to the
SVC. The two openings are sewn together, directing the blood flow to the lungs.

Figure 4 Stage 2 Bidirectional Glenn procedure[23]
1.2.3

Surgical Stage 3

The third stage is named Fontan after Francis Fontan, a French surgeon, who introduced this
operation in 1970 and since then became the final palliation stage for HLHS patients[24]. The
Fontan operation performed when patients are 18 to 36 months old. During this operation, the
inferior vena cava is dissected off the right atrium and anastomosed to the pulmonary arteries using
Goretex (Fontan) conduit establishing a total cavopulmonary connection (TCPC).
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Figure 5 Extracardiac Fenestrated Fontan Operation [25]
For most Fontan patients, a fenestration in the conduit is created, which could be helpful,
especially when high pulmonary vascular pressure presents. A study by Bridges [26] found lower
mortality and shorter hospitalization for Fontan patients with fenestration[26]. After this operation,
the right ventricle now pumps oxygen-rich blood only to the systemic circulation, and oxygenpoor blood returns passively to the lungs. However, Fontan physiology has some complications
such as plastic bronchitis, protein-losing, renal and liver failure, and more complications that affect
the patient's quality of living negatively[27, 28].
Although this staged operation has been widely adopted and optimized for years, studies
reported that the survival rate at the age of five ranges between 58-72% [29-31]. Recently, a center
reported that the surviving rate is only 40% for patients undergone the three surgical operations by
the age of 10 years old [32]. The heart failures can be due to ventricular dysfunction, elevated
pulmonary vascular resistance (PVR), and high inferior vena cava (IVC) pressure, which lead to
8

death. Over the years, many improvements have been suggested to the Fontan; some suggested
using a mechanical pump to push the blood to the pulmonary circulation. However, pumps have
issues like causing recirculation and obstruction, and cannot be shut off [33-36]. Others proposed
using different diameters and locations for inferior cavopulmonary connection (ICPS) or use Yshaped ICPS [37-41]. Gewillig M. et al. [42-44] in their work explained in detail the Fontan
complications such as low flow pulsatility, high pulmonary vascular resistance, and
underdeveloped pulmonary vasculature. Moreover, a fenestration at the inferior vena cava was
proposed to reduce the IVC pressure and improve the cardiac output by returning some of the IVC
flow back to the right atrium. However, that can decrease the oxygen saturation and causes
cyanosis if the returned IVC flow was high.
The current survival rate is about 70% after the Norwood procedure. However, high
mortality was reported for a subset of patients after the Norwood operation [45]. Moreover, with
the current three staged procedures still only 63-80% of infants survive at one year of age [22, 4648] and the need for less invasive palliative treatment that mitigate the risk factors such as low
birth weight and aortic atresia, several variants (hybrid) staged surgeries have been proposed in an
effort to improve success of the HLHS palliative treatment by delaying the more invasive operation
until patients become more mature[49-51]. Although the Norwood procedure has become for a
long time the standard option to treat patients with a single ventricle, it is still not a viable option
for many patients because of its complexity that requires patients to be clinically stable before
undergoing the procedure. Moreover, in some cases, surgeons cannot perform the Norwood
procedure if the patient is prematurely born or has a serious illness that needs to be treated
immediately like neonatal sepsis.
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In 1993, Gibbs et al. introduced a less invasive approach without the use of
cardiopulmonary bypass, which can cause bleeding, platelet dysfunction, inflammatory, and
coagulation, etc.[52, 53] . The hybrid Norwood procedure consists of three steps: (1) a band is
placed on both branches of the pulmonary artery to balance the blood flow between the systemic
and the pulmonary circulations and to control the pulmonary flow, (2) stenting the patent ductus
arteriosus (PDA) to prevent it from closing to allow blood circulation from the right ventricle
into the systemic circulation, (3) a balloon atrial septostomy is performed to provide an opening
between the left and right atria to allow blood flow from the lungs to the right, atrium[49, 51, 52,
54]. Both, the classic and the hybrid procedures attain the same physiological goals but the hybrid
is less invasive and, in both procedures, the systemic and the pulmonary circulations are fed by the
main pulmonary artery and have the same oxygen content. The hybrid procedure was reported to
be adopted in many centers around the world, in Japan [55], Brazil [56] and Germany [57] with
low mortality compared to the classic Norwood [50, 58]. However, the hybrid approach can cause
complications such as retrograde aortic arch obstruction (RAAO), which is an obstruction that
occurs in patients who underwent the hybrid Norwood. The RAAO was reported to occur in 1024 % of patients, and it can increase the number of deaths between infants with this issue[59, 60].
The degree of stenosis varies between patients before undergoing the second stage [59, 60].
Another complication for post-operative patients is the migration of stent and PAs band, this can
happen due to incorrect placement. A review study reported 100% (3 out of 3) mortality of patients
with low birth weight and aortic atresia who underwent initial branch pulmonary artery banding
(bPAB) and also reported a high mortality risk among premature patients after bPAB [61]. Another
study found that the hybrid procedure is a safe alternative for high-risk patients who have organ
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dysfunction after reviewing data of 10 patients from one center with ductal-dependent systemic
outflow obstruction [62].

Figure 6 Hybrid Stage 1 Procedure[63]
The Comprehensive Stage II procedure, which follows the Hybrid Norwood, was
performed for the first time by Hakan Akintuerk in 1998 [64]. The Comprehensive Stage II
procedure, which takes place at 4-6 months of age, involves: (1) PDA stent removal, (2) pulmonary
arteries band removal, (3) reconstruction of the aortic arch, (4) atrial septectomy, and (5)
Bidirectional cavopulmonary anastomosis creation. The comprehensive stage II establishes the
same physiology as the Glenn procedure.
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Figure 7 Comprehensive stage 2 procedure[65]
Only few centers reported the outcomes of the comprehensive stage II procedure. A center in
Germany reported that 81 (91% survival) patients survived after comprehensive stage II (8 died
out of 89 patients)[58] and another center in Canada, reported ( 6% mortality ) two deaths out of
32 patients [66]. The comprehensive stage II procedure is more complex and requires aortic arch
and pulmonary artery reconstruction. Moreover, a study found that there was no difference in
survival rate between the Norwood and hybrid I patients up to 3 years after the second stage
procedure. The study reviewed 43 Norwood patients and 32 hybrid patients who underwent the
first procedure. The survival rate at one year was 83.8% for Norwood and 85.6% for the hybrid
group and 80.4% versus 85.6% after three years[66]. A higher PA intervention, 20 interventions
in hybrid (31 %) versus 5 in Norwood (11%) after few months, and less developed PA in hybrid
patients was reported by the same study [66]. At three years, 43.3% of the hybrid group needed
intervention versus 11.9% for the Norwood group [66]. A study by Venugopal [67] of 21 patients
undergone the hybrid stage I and II showed higher mortality than the standard Norwood operation.
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The mortality rate was 42 % (9 died out of 21 patients).The same study reported higher necrotizing
enterocolitis (NEC), which is an infection that affects the intestine, incidents in hybrid patients
(23.8% versus 18% for Norwood patients) [67]. A study carried out by Naguib [68] to review and
evaluate the pain management after comprehensive stage II and compare the results with Glenn
patients. A total of 57 patients' data was reviewed, 36 patients underwent the comprehensive stage
II, and 21 underwent the Glenn procedure. The study reported not only a higher pain scores after
the comprehensive stage II but also a greater amount of fentanyl, which is the initial opioid
prescribed for most patients in this study. The higher requirements of opioids were due to the fact
that the comprehensive stage II requires reconstruction of the aorta, longer time operation and
bypass usage, and longer mechanical ventilation for the majority of patients[67, 68]. A similar
interstage mortality and morbidity rate between two groups of patients (14 hybrid and 19
Norwood) who underwent the second stage palliation was reported [51]. A study reported the
outcomes of 41 patients undergone the hybrid procedure between 2005 and 2013, where 17 of
them had a low body weight (average 2.6 kg). There were 13 inpatients, and interstage deaths were
reported after the hybrid procedure. Furthermore, 28 survivals, 13 underwent the comprehensive
stage II, 4 underwent biventricular repair, and 11 underwent the Norwood procedure. The study
found that the survival rate after the comprehensive stage II compared with the Norwood procedure
as a second procedure was inferior. Four deaths were reported in the same study of patients
undergone the comprehensive stage II, while no death was reported of patients who underwent the
Norwood procedure [54]. Similar median and long term survival of patients undergone stage I
Norwood or the comprehensive stage II following branch pulmonary artery banding (bPAB),
similar transplant-free survival was reported by Davies [61]. The same study found that there were
no benefits of delaying the comprehensive stage II to mitigate the risk factors like low birth weight
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[61]. One study reported excellent outcomes of patients undergone the comprehensive stage II
following the hybrid stage I. The mortality was reported to be 4% (2 out of 55) patients after the
comprehensive stage II [69].

1.3 General Introduction
This project aims to study the Hybrid Comprehensive Stage II, which is a new surgical
palliative procedure for single-ventricle disease by using multiscale modeling with CFD.
Congenital heart disease (CHD) is the main cause of death for children with congenital disabilities
and affects 1% of the newborns in the U.S, according to the Center of Disease Control and
Prevention [70]. Infants born with one working ventricle make up 25 % of patients with CHD,
and about 30-40 % of them die at the age of five and rises to about 50% by the age of 20 years
[59, 71, 72]. Moreover, surgical palliative treatment of CHD could cost up to 1 million per patient
in the first five years [73, 74]. Infants with a single ventricle need to undergo staged surgical
procedures to reroute the blood flow and restore the heart function. The Norwood procedure is
considered the major stage where the cardiopulmonary bypass is performed, and it was reported
that the Norwood procedure has the highest risks of mortality [70].
Approximately 30% of patients do not survive after the initial Norwood operation, and this
percentage is higher for a subset of newborns, especially patients who weigh less than 2.5 kg [59].
Consequently, in order to increase the number of survivals, three chained hybrid operations were
proposed as an alternative to avoid the cardiopulmonary bypass and the circulatory arrest [59]. In
the first operation called the Hybrid Norwood, the left and right pulmonary arteries flows are
restricted with a band to balance the flow between the to the lungs and the rest of the body.
Moreover, a stent is placed in the patent ductus arteriosus in the pulmonary trunk to allow blood
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circulation from the right ventricle into the systemic circulation [75]. However, the first stage is
followed by a more complex procedure called the comprehensive stage II, consisting of
cardiopulmonary bypass, hypothermia, ductal stent debridement,aortic arch reconstruction,
Damus-Kaye-Stanzl (DKS) connection, cavopulmonary anastomosis, and atrial septectomy [65].
In some centers, the morbidity and mortality rates of the comprehensive stage II are greater than
that of the traditional stage II operation [59, 66]. Therefore, there remains concerns that the
“hybrid” strategy, as currently conducted, may not confer a net morbidity or survival advantage to
the patient.
The hybrid comprehensive stage II was recently proposed at Arnold Palmer Hospital to
further reduce the trauma of the comprehensive stage II [76]. The HCS II is applicable to the subset
(30-50%) of single ventricle patients that have sufficient antegrade aortic flow to sustain upper
body perfusion. Such patients may include an unbalanced atrioventricular canal, double inlet left
ventricle, tricuspid atresia with ventriculo-arterial discordance, mitral atresia with large ventricular
septal defect (VSD), and some cases of hypoplastic left heart syndrome with mitral and aortic
stenosis. The technique avoids the creation of a DKS connection and surgical arch reconstruction
entirely and, with further technical development, may be achieved without hypothermia, cardiac,
and circulatory arrest[76]
The procedure is designed to follow the hybrid stage 1 approach to single ventricle repair.
It requires a limited incision into the main pulmonary artery (MPA) and avoids dissection of the
branch pulmonary arteries. A stent is placed to reinforce a baffle that bridges the Ostia of the
branch pulmonary arteries, helping to support the compressive load from hemodynamics of the
neo-aorta. In addition, to avoid stent migration, given the strong stresses exerted by the systemic
circulation, the stent is sutured onto the orifice of each branch pulmonary artery[76]. The MPA
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is then patched, and the stented ductus is re-stented with a bare-metal stent to maintain patency.
The stented ductus may lead to distal arch obstruction, as it does in the Hybrid Norwood, and in
the extreme case of total arch obstruction, the upper-body systemic flow is separated from the
lower-body

systemic

flow.

Figure 8 Hybrid Comprehensive Stage II Operation[76]
Short-time operation, as well as shorter hypothermia, are among the potential advantages
of HCS II[76]. But like other procedures, the HCS II has some potential disadvantages, and that
includes left pulmonary artery and ductal arch stenosis and thrombose formation in areas where
low shear stress or circulation occurs. Moreover, due to the presence of two different forces acting
on the stent, one of which with high pressure flowing externally and the other force with low
pressure, stent distortion may occur. Finally, the most important condition for patients to undergo
this surgery is the adequate size of the ascending aorta as mentioned earlier. For some patients, the
ascending aorta development might take longer than others, and that can lead to insufficient upper
body blood flow[76].
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Figure 9 Schematic of the Hybrid Comprehensive Stage II Procedure
Given the novelty and complexity of the resultant circulation, we developed a multiscale
computational fluid dynamics model to explore the overall HCSII hemodynamics. The specific
aims of this dissertation are:
Aim 1: Obtain de-identified angiographic images for a patient who underwent the HCS II
operation recently to extract a patient-specific geometry as well as waveforms for validation.
Generate a synthetic representative model of the HCS II and generate the CFD mesh model. Finally,
tune the 0D LPM circuit to generate the boundary waveforms needed for the CFD.
Aim 2: Utilize the developed multiscale CFD model to obtain: (a) the flow profile through
the stented baffle and to investigate the pressure drop across the baffle and the tendency of forming
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blood clots. (b) The flow near the aortic isthmus to see if there is any indication of thrombosis
formation.
Aim 3: Determine the lower limits of aortic root/ascending aortic diameter that assure adequate
cerebral blood flow. This will be accomplished in our computational model by: (1) synthetically
narrowing the ascending aorta of the patient-specific solid model using the Software Solidworks
(Dassault Systemes, Concord, MA) and (2) running the multi-scale CFD simulation holding the LPM
parameters constant and that will aid in predicting suitable patients (i.e., magnitude of antegrade aortic
flow) for the HCS2 operation.
Aim 4: Calculate stresses on the outer surface of the inter-pulmonary baffle and estimated
resulting deformation of the stent over short time scales.
Aim 5: Calculate the energy losses in the flow from the main pulmonary artery to the

descending aorta.
Aim 6: Construct an oxygen transport model and calculate the oxygen delivery as a
function of aortic root size and flow split ratio.
Aim 7: Calculate the particle residence time PRT, which can help identify the area of
circulation and stagnation.

18

CHAPTER TWO: LITERATURE REVIEW
Computational fluid dynamics (CFD) using coupled multiscale modeling has been used
widely to obtain physiologic information and compare different surgical approaches. In particular,
the CFD tool has been used to predict the hemodynamic changes in single-ventricle patients [29,
39, 40, 77-84]. The use of CFD in such cases was due to a lack of animal models and the difficulty
of conducting clinical measurement [41]. CFD modeling was first used in aerospace and
automotive engineering and then became a crucial tool in biomedical research to develop and
improve medical devices, cardiovascular research, and surgical planning [85].
The hybrid Norwood procedure was modeled by Ceballos [73] when he investigated the
effect of different reverse-Blalock-Taussig shunt diameter (RBTS) on the hemodynamics and
found out that the 3.5 mm had lower thrombus formation risks and lower shear rates than the other
two cases (3.0 mm and 4.0 mm). He also modeled the hybrid Norwood procedure with distal aortic
arch obstruction and an RBTS. Four synthetic models were analyzed in this study, with and without
90 % stenosis and with and without RBTS 4.0 mm. Using loosely coupled schemed showed that
4.0 mm RBTS completely compensate for the 90 % obstruction restoring the pressure to the
nominal levels [74].
Corsini [86] studied the influence on cardiac output and oxygen delivery as the branched
pulmonary arteries (BPA) banding, and ductal stent diameter varied. In this study, he found the 2
mm BPA to be optimal and that the cardiac output is more sensitive to changes in BPA than the
changes in ductal diameter.
Hsia [87] developed 3D models of the hybrid stage 1, the Norwood procedure with MBTS,
and the Norwood with right ventricle to pulmonary shunt to investigate the difference in oxygen
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delivery and blood flow to the head and the rest of the body. Multi-scales models were utilized in
this study by coupling the 3D models to the 0D LPM model of each procedure. The results showed
a reduction in the systemic oxygen delivery in the hybrid case, 475 mL/min/m2 compare to RVS,
640, and MBTS 475 mL/min/m2. Moreover, the coronary perfusion pressure was found to be
higher in the MBTS and RVS than the hybrid procedure.
Prather[88] carried out a loosely coupled multi-scale CFD analysis to study the relationship
between the reverse Blalock –Taussig shunt size and placement influence on embolism formation.
Moreover, a non-Newtonian blood model, patient-specific geometry, was implemented in this
study. He used a Lagrangian phase model to track individual particles in order to investigate the
pattern of embolization. The study showed that the stroke decreases by about 20 % when there is
a distal arch obstruction, and the shunt size has a small effect when no stenosis present. However,
when 90% of stenosis introduced, the stroke is sensitive to the shunt size. Moreover, the 3 mm
RBTS could help to reduce the cerebral and coronary thromboembolic but no effect on the
pulmonary.
Bove [29], in this study, compared the effect of the right ventricle artery shunt and the
RBTS in standard Norwood. The results showed that in the case of right ventricle shunts, a better
oxygen delivery was displayed. On the other hand, the RBTS had more negative effects on the
hemodynamics.
Migliavacca [89] developed 3-synthetic models of Norwood procedure with different
shunt placement locations : (1) Blalock-Taussig shunt connecting the innominate artery to the
pulmonary artery, (2) Central shunt (CS) connects the aorta to the pulmonary artery(3) right
ventricle to pulmonary artery shunt, known as San operation(SO). The multiscale approach was
utilized to couple the 3D CFD model with the 0D LPM model of each geometry and different
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shunt sizes were investigated (3, 3.5, and 4 mm). The results showed that the SO shunt produces
minimal backflow, lower pulmonary to systemic flow ratio, and higher coronary pressure. Laganà
[90] carried out a multiscale CFD model to compare the changes in pulmonary and the coronary
blood flow dynamic of Norwood patients between using the Blalock-Taussig shunt (MBTS) and
the central shunt (CS). Different shunt sizes (3, 3.5, 4 mm) were investigated. The CFD results
showed: (1) The cardia output was higher with the CS, (2) The pulmonary flow increases as the
shunt size increases in both models, (3) Unbalanced right and left pulmonary flow.
Satoshi [91] developed the chimney reconstruction, which consists of a longitudinal
extension and horizontal plication with the absence of path supplementation to prevent turbulent
blood flow, neoaortic root dilation, as well as enabling low energy loss. Satoshi and his team
utilized computational fluid dynamics (CFD) analysis to investigate the ideal configuration of the
reconstructed aortic arch using patient-specific models. The results showed laminar flow in the
reconstructed aortic arch, specifically, in the isthmus at systole. Vortex flow in the neoaortic trunk
was also observed at diastole. In reality, the patients showed low wall shear stress in the isthmus,
along with low energy levels. Meanwhile, the CFD results showed a moderately high oscillatory
shear index with low wall shear stress in the small portion of the neoaortic trunk.
Migliavacca [92] proposed a procedure of calculating the blood flow in a systematic to
pulmonary artery shunt using CFD models based on the finite element method to calculate the
velocity profiles in the shunt. With a varying shunt size from 3-5 mm, velocity profiles were
evaluated at the distal and proximal positions, and correlations were drawn between the mean and
maximum spatial velocities. The CFD results showed that the distal shunt Doppler velocities were
always less than the proximal ones. The CFD models showed a
junction and a ratio of 0.48 at the proximal one.
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ratio of 0.579 at the distal

Studies have found that the Sano shunt provides a more stable hemodynamics state and
low mortality compared to MBTs [93]. Moreover, a study found that using a conduit between the
right ventricle and the pulmonary artery

produces a better systemic and pulmonary flow

distribution compared to the systemic to pulmonary conduit after reviewing the hemodynamics
data of 24 patients,10 with systemic to pulmonary artery conduit and 14 with right ventricle to
pulmonary artery shunt [94]. The current survival rate is reported to be about 70 % after the
Norwood procedure [47]. However, high mortality was reported for a subset of patients after the
Norwood operation [45]. Risk factors like low birth weight, intact atrial septum, genetic
syndromes, and small ascending aorta have a negative impact on survival for patients after the
Norwood procedure [58, 95-100]. Moreover, It was reported that the death rate of patients who
underwent Norwood operation was 40 % and 46 % at the age of 1 and 5 years, respectively[101].
The shunt design in stage 1 palliation has been the focus of numerous studies due to the
fact that it controls the flow split between the pulmonary and the systemic and controls the pressure
in both circulations. Many studies have been conducted on vessels with branches or bends, which
can cause diseases such as arteriosclerosis (fat built up in arteries) and thrombus [102, 103]. For
those reasons, several researchers have been investigating the design parameter s of the shunt like
diameter and angle of insertion.
Song [104] developed three synthetic models of a Norwood procedure with Blalock
Taussig shunts and used CFD as a tool to study the blood flow of three different diameter shunts
(3 mm,4mm, and 5 mm). The study showed that the shear stress was higher when using 3 mm and
4 mm shunt sizes but higher energy losses were observed compared with the 5 mm model. A study
by Sant’Anna was conducted to find the effect of Blalock Taussig shunt diameter and the angle of
anastomosis on the blood hemodynamics. The models used in this study were built based on
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average patient data, and the blood was modeled as a Newtonian fluid. The study showed that the
angles between 60 to 90 deliver higher pulmonary flow, and the shunt diameter is the main factor
in regulating the amount of blood flow[105]. Waniewski [106] utilized CFD tools along with in
vitro simulation to estimate the hemodynamics of the Norwood procedure with Blalock Taussig
shunt. Another study by Migliavacca [107] investigated, by using a mathematical multiscale CFD
model, how the shunt diameters (3,3.5,4,4.5 and 5 mm), systemic and pulmonary vascular
resistances and the heart rate affect the blood flow distribution and oxygen transport. This model
showed that the 5- mm shunt increased the Qp/Qs but dropped O2 delivery. Moreover, the effect
of heart rate on O2 delivery was minimal. Finally, Qp/Qs =1 was optimal for O2 delivery.
Moghadam et al., in their simulation, coupled the lumped parameter network of a Norwood
anatomy to a 3D finite element solver. This study aimed to obtain the optimal shunt diameter,
angle and patching location that provide the best systemic and coronary oxygenation. The
simulation found that small distal shunt increases the systemic flow, while a more proximal shunt
increases the coronary oxygen deliveries[108]. In 1995, Kitagawa and his group published a paper
that aimed to find the optimal shunt diameter that provides the best flow to the lungs for Norwood
patients. The study suggested using a shunt diameter that ranges between 3.0 mm and 3.5 mm to
obtain suitable pulmonary flow [109].
Pennati and his group studied in vitro the effect of anastomotic dispensability, and suture
restriction affects the pressure-flow relationship as a follow up of another numerical study carried
out by the group (Migliavacca 2000). Two Gore-Tex shunts (3 mm and 4 mm) were used in this
steady flow study, and the results showed that the pulmonary artery pressure has an impact on the
pressure-flow relationship but presents no influence on the total pressure drop across the
shunt[110].
23

Other studies have focused on determining the optimal Qp/Qs for Norwood circulation
since this ratio affects the oxygen delivery of the system. A study by Barnea ,where a mathematical
model was used, found that (i) the systemic oxygen increases as the Qp/Qs increases and then
starts dropping ,(ii)the optimal ratio was found to be less than or equal to 1,(iii) the Qp/Qs ratio
drops as the cardiac output increases[108].
Moreover, there have been plenty of studies regarding the Glenn procedure. One of which
reported the major cause of death for standard Glenn patients was due to insufficient pulmonary
flow after collecting data of more than 500 patients [111].
Shiavazzi [112] studied how different left pulmonary artery stenosis affects the
hemodynamics for Glenn patients by using multiscale CFD analysis. Data from 6 patients were
used in this study to produce the 3-dimensional model, and by using mesh morphing, he was able
to vary the LPA stenosis level. The study showed a minor effect on the hemodynamics of the
superior cavopulmonary connection when the stenosis is less than 65 %, but it is recommended to
use LPA arterioplasty when the stenosis above 65 %.
Esmaily-Moghadam [113] analyzed an assisted bidirectional Glenn (ABG) using CFD. A
shunt was placed to connect the right innominate and the superior vena cava. He also used a clip
in one of the three models used in this study to constrict the flow near the SVC to create a Venturi
effect. The study showed that ABG provided higher oxygen delivery and pulmonary blood flow
than modified Baloch-Taussig shunt but higher SVC.
Zhou and his group [114] used an in vitro model to validate the simulation results carried
by [115 259]. The results showed a mean pressure difference of 1.2 mmHg and that the ABG
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increase the systemic oxygenation by about 30 %. However, they also found an increase in SVC
pressure.
Another alternative to the bidirectional Glenn procedure is the Hemi Fontan, where the
right atrium is constructed by using a baffle to direct the SVC flow to the lunges. Bove [116], in
his study, used computational fluid dynamic techniques to compare the hemodynamics between
the Hemi-Fontan and the bidirectional Glenn as well as Fontan procedure with different models.
The models (the Hemi-Fontan procedure (HFP) and the bidirectional Glenn anastomosis (BDG)
after the Norwood procedure and the lateral tunnel (LT), total cavopulmonary connection (TCPC),
and extracardiac conduit (ECC)) were constructed based on average clinical data). The study found
that the Bidirectional Glenn and the Hemi-Fontan produce similar blood distribution and energy
losses while the lateral tunnel energy loss was less compared to the other Fontan models (TCPC
and ECC).
Kung [41] constructed two patients specific models from magnetic resonance imaging and
a total of four simulations carried out with resting and active conditions for both models. The study
demonstrated big differences in power losses between the two cases and different hemodynamic
properties due to physiological differences.
The shear stress on the arterial walls was also investigated by Strony [117], who analyzed
the effect of a high wall shear stress on thrombus formation.
Holme [118] found in his experimental study that aimed to find the relationship between
shear rate and thrombus formation, that thrombus formation started at shear rate of 10500 1/s.
Also, Baumgartner [119] and Sakariassen [120] both investigated the effect of shear rate and shear
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stress on the thrombus formation. These studies showed that as the shear rate increases the risk of
thrombus formation increases as well.
Troianowski [121] developed 5-patients specific geometries from MRA data and imposed
pulsatile boundary conditions from their clinical data. The aim was to examine the hemodynamics
of each model. The CFD results showed that the power loss was low and linearly proportional to
the cardiac index in all models and low wall shear stress. Moreover, this study results showed
some differences in results between the models, which emphasize the importance of patientspecific simulation.
Kung and his colleagues developed two patients' specific geometries of stage 2 with HemiFontan based on magnetic resonance imaging. The 3D- geometrical model was then coupled to
0D lumped parameter models to describe the entire circulation. The CFD results showed swirling
in the Hemi-Fontan in both models, and the power loss was similar, less than 13% in the pulmonary
circulation. However, the swirl and stagnation levels were higher in one model than the other, and
that shows the importance of stimulation of patient-specific models [122].
Pekkan et al.[123] studied, using CFD tools, two-second stage models (Glenn and HemiFontan). Both geometries were constructed based on clinical data. The Glenn models showed
better hemodynamic and flow performance compared with the Hemi-Fontan model. Moreover, by
comparing the power loss of the second stage models (Glenn and Hemi-Fontan) with the total
cavopulmonary connection model (TCPC), it was noticed that the power loss of the TCPC model
was higher. The mortality rate after the second stage ranges from 0 % to 8 %, which is better than
the first stage mortality by far [111, 124].
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Moreover, the third stage of single ventricle palliation procedures called Fontan, which
was named after Frances Fontan who completed the first Fontan ever in 1968 by repairing tricuspid
atresia in the right ventricle. Since then, the procedure was performed on several numbers of
patients. However, ventricle dysfunction and an increase in the pulmonary vascular resistance
could lead to death in some cases. In other cases, a Fontan failure can be due to Inferior vena cava
pressure rise, which can damage the liver [43, 125]. Moreover, researchers have been using the
CFD tools to quantify the hemodynamics of Fontan and to help optimize the procedure [126-129].
One of the studies by Alexi-Meskishvili [130] aimed to determine the right size of the Gore-Tex.
Moreover, 20 patients participated in this study and the results showed that using a conduit with a
diameter that doesn’t exceed 20 % of the IVC diameter is recommended to lower the risks of
thrombus formation, and it is optimal to perform the extracardiac Fontan operation at 2-4 years of
age at a bodyweight of 12-15 kg.
Itatanis [40] also investigated the optimal size of the extracardiac Fontan operation. The
size of the conduit varied between 14 mm and 22 mm. Moreover, a synthetic model was built
based on data from 17 patients. This study showed that the conduit sizes between 16 mm and 18
mm displayed less energy loss and reduced flow stagnation while the larger conduit size displayed
backflow.
Ni [131] investigated a self- powered Fontan circulation that injects energy into the right
and left pulmonary artery to in order to drop the inferior vena cava pressure by 3-5 mmHg. A
tightly coupled scheme at the time step level with the 3D CFD model was used in this study. A
synthetic model of Fontan patients and two patients -specific geometries 10 and 24 years old were
investigated with different IJS nozzle diameter and IJS placement along the Pulmonary artery. The
study showed a drop in the IVC pressure and pressure and flow increase in the pulmonary system.
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Pulsatile and continuous mechanical pump devices have been proposed and studied by
many researchers to mainly increase the pulmonary arteries flow pressure. Delorme et al.[132]
proposed a viscous impeller pump (VIP) inserted in the center of the TCPC connection. The largeeddy numerical simulation used in the study showed that the VIP: (i) does not obstruct the flow,
(ii) reduces the instability and the turbulence, (iii) the VIP at high rpm (100-2000 rpm) decreased
the IVC pressure.
Pekkan et al.[34] modeled three pump configurations :(i) upstream TCPC baffle (ii)
downstream TCPS baffle, (iii) at the TCPC using computational fluid dynamics. The results
showed the upstream pediatric ventricular device VAD) caused a higher pressure in the IVC while
the downstream VAD led to graft collapse. Moreover, the VAD in the TCPS intersection was
preferred because of its simplicity and ease of use.
Shimizu et al.[133] used CFD as a tool to analyze the performance of placing a rotational
pump between the IVC and the PA. The multi-scale approach results showed that the PA pressure
increased while the IVC and SVC pressure decreased. However, the SVC flow was decreased.
Mackling et al.[134] reported successful implantation of a Berlin Heart EXCOR Pediatric
VAD for patients who had Glenn procedure.
Rodefeled and Tsuda [135, 136] reported low IVC pressure after continuous pump
implantation in sheep models mimicking the Fontan procedure.
Even though the Pediatric ventricular devices (VADs) have shown promising results, they
can lead to more complications for Fontan patients: (1) increase the infection risk,(2) increase the
thrombosis risk [137],(3) increase of bleeding risk because of using anticoagulation therapy
[138],(4) suction and blood cavitation that can cause collapse [139, 140]
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CHAPTER THREE:
MATERIALS AND METHODS
3.1 The Model
There will be two models employed in this study: (a) a synthetic model representative of
the HCS II, and (b) a patient-derived model obtained from de-identified MRI scan. SolidWorks
(Dassault Systemes) was used to build a synthetic 3D model for a patient with dimensions gathered
from X-Ray angiography images provided by the Arnold Palmer Hospital of a patient who recently
underwent the procedure. The geometry includes the main pulmonary artery (MPA), branched
pulmonary arteries (left=LPA, right=RPA), the descending aorta (DA), the ascending aorta (AA),
right and left coronary arteries (RcorA, LcorA),right and left carotid arteries (RCA, LCA) and
right and left subclavian arteries (RSA, LSA) as shown in Figure 10. Future models will be patientspecific models, and the 3D geometry is gathered through CT scans by using the medical
segmentation software MIMICS as indicated in aim 3.

Figure 10 Dimensions of the synthetic model (in millimeters)
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This 3D model will be the basis for the investigation of the detailed hemodynamics of the
HCS II. However, the pulsatile boundary conditions that drive this CFD model must be provided
and must be representative of the peripheral circulation. Consequently, it is common practice in
a multiscale CFD analysis to utilize a reduced 0D lumped parameter model of the peripheral
circulation that is either loosely or strongly coupled to the 3D CFD model for this purpose [88,
141, 142].
In order to carry out the study in aim 2, section 1.1, that targets to elucidate the relationship
between the baffle narrowing and the pressure drop in the main pulmonary artery as a function of
the area over the baffle as shown in Figure 11. The synthetic geometry was modified, and 5synthetic geometries were constructed with a different area over the baffle sizes. Table 8 shows all
the various narrowing measurements used in this study. Figure 12 shows the locations where the
pressure was measured in this study to determine the pressure drop; more details can be found in
section 4.4.

Figure 11 H represents the minimum distance between the surface of the systemic baffle surface
and the outside surface of the pulmonary trunk
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Figure 12 Locations where the pressure was measured to calculate the pressure drop.

Figure 13 Synthetic model configurations :( Top Left) Nominal, (top Right) -15%,
(Bottom Left ) +10%,(Bottom Right) +15%
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Furthermore, one of the main goals of this dissertation is to determine the lower limits of
aortic root/ascending aortic diameter that assure adequate cerebral blood flow. Therefore, different
aortic root configurations were built using SolidWorks (Dassault Systemes), as shown in Figure
14, the AO diameter was manipulated with ± 15%. In this study, the oxygen delivery was
calculated as a function of the aortic root size and also how the aortic diameter would affect the
flow field.

Figure 14 Different ascending aorta configurations
3.2 Patient-Specific Model
Advanced medical imaging and image processing have been developed and utilized since
1990 to stimulate blood flow [143-145]. Constructing patient-specific geometries can be done
using in vivo non-invasive imaging technologies such as X-ray, ultrasound, computed tomography
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(CT), and magnetic resonance imaging [146, 147]. The next step after data acquisition is to
construct the area of interest using 2D or 3D segmentation. The anatomical model surface can be
represented or defined using discrete techniques that approximate the model surface by
triangulating it or using functions that analytically describe the geometry; an example of that
method is b-spline.
Moreover, the 2D segmentation demands a high user interaction but can deal with lowquality images. On the other hand, the 3D segmentation is easier to utilize especially with high
data quality[148]. Arnold Palmer Hospital provided the 2D images for a specific patient by using
a Computerized Tomography (CT) scan. The 2D images were then converted to a 3D geometrical
model by using the combination of two commercial software, the Materialize Interactive Medical
Image Control System (MIMICS) (Materialize, Leuven, Belgium),software, which is an image
processing software that was used to convert the 2D images into 3D model, and 3-Matic. The latter
is built-in advanced CAD software that comes with IMICS and can be used by users to perform
different operations such as remeshing, fixing and making design changes, etc. to develop the final
3D model. The final 3D model was then imported to STARCCM+ to stimulate the fluid domain
in the area of interest. The patient-specific model consists of the following vessels: the main
pulmonary artery, the ascending aorta, the descending aorta, the right and left coronaries, and the
left and right subclavian and carotids. MIMICS did not reconstruct the ductal stent area because
of the poor resolution and the contrast of the CT images. As such, a synthetic loft was created
using 3-Matic to connect the main pulmonary artery and the descending aorta, as shown in Figure
15. Also, the left and right coronaries were synthetically modeled in the patient-derived geometry
by using Solidworks (Dassault Systemes, Waltham, MA) for the same reasons mentioned above.
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Figure 15 Three Dimensional Patient-Specific Model of a Post-Operative Hybrid
Comprehensive Stage II Segmented from MRI Scan

3.3 Boundary Conditions
Boundary conditions accuracy is very important since they have a vital role in determining
the dynamic results of the multi-scale simulations. Furthermore, boundary conditions type have
also a big impact on the system dynamic [149, 150]. Currently, PC-MRI, ultrasound, and
catheterization have made it possible to obtain very sophisticated boundary conditions such as
pressure and velocity of patients specific and incorporate the clinical data in computer simulations.
Moreover, numerous studies have used Lumped Parameter Models introduced by Fry and
Greenfield [151] to couple the flow rate and pressure of the CFD to the LPM. The Navier-Stokes
equations used to study blood flow require boundary conditions prescribed at the boundaries of
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any model to be able to represent the three-dimensional motion of the flow. It is worth to mention,
that it is not possible with the current technologies to model the whole human circulatory system
for two reasons: (1) current imaging techniques can not characterize small vessels, which can be
as small as 3.7 microns in the capillaries[149, 152, 153], (2) current hardware and software cannot
computationally handle such a long circulatory system which can range between 60,000 miles
and 100,000 for children and adults, respectively. Thus, only the area of interest is modeled in the
3D CFD simulation. In this study, the boundary conditions were defined at each face of CFD
geometry. STARCCM+ users have the option to specify the desired boundary condition type
(pressure outlet, stagnation inlet, etc.) at each inlet and outlet. In this study, the boundary
conditions imposed: a stagnation inlet at the pulmonary artery (PA) and mass flow rates inlet and
an outlet for the rest (SVC, RPA, LPA, RCORA, LCORA, RCA, RSA, LCA, and LSA). Arnold
Palmer Hospital in Orlando provided clinical data of a patient who underwent the HCS II
procedure. A sample of the catheterization data provided is shown in the table below.
Table 1 some of the catheterization data provided by Arnold Palmer Hospital.
Boundaries

Type

Physics Quantity

Main pulmonary artery (MPA) Stagnation inlet

Pressure

Ascending aorta (AO)

Stagnation inlet

Pressure

Descending Aorta (DA)

Mass flow outlet Mass flow

Right coronary (R_Cor)

Mass flow outlet Mass flow

Left coronary (L_Cor)

Mass flow outlet Mass flow

Right subclavian (RSA)

Mass flow outlet Mass flow

Left subclavian (LSA)

Mass flow outlet Mass flow

Right carotid (RCA)

Mass flow outlet Mass flow

Left carotid (LCA)

Mass flow outlet Mass flow
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Table 2 Boundary conditions imposed in this study
Part

Value

HR

120 bpm

CO

2.99 l/min

Qp/Qs

0.6

R/L pulmonary flow

0.42

PA average pressure

65 mmHg

AO ascending average pressure

65 mmHg

AO descending average pressure

54 mmHg

SVC average pressure

9 mmHg

Right pulmonary artery average pressure 8 mmHg

3.4 Lumped Parameter Model
The LPM is a simplified model that has been widely used to model the part of the circulatory
system outside the 3D region by many studies [29, 87, 90, 154, 155]. The Windkessel was first
described by Otto Frank to represent the heart and arterial system back in 1899 [156]. The LPM
can be tailored to represent any patient’s anatomy or clinical data. The HCS II circulation can be
modeled using a multi-degree of freedom Windkessel, which is used to describe the heart pumping
load through the systemic or pulmonary flow and the relation between the blood pressure and flow.
The LPM is an electrical analog of the circulatory system [87] that models viscous drag as a resistor
(R), vessel compliance as a capacitor (C), flow inertia as an inductor (L), and valves as diodes.
The HCS II circulation is divided into multi coupled beds for simplicity, and these beds are known
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as a multi-degree of freedom Windkessel models. Each bed consists of resistors capacitors and
inductors, which can be time-dependent [40]. The HCSII model consists of 5 subsystems: the right
ventricle, the upper circulation, the lower circulation, the coronaries, and the pulmonary
circulation. The systemic circulation consists of 7 arterial compartments, the pulmonary circulation
has four compartments, and the coronary circulation is divided into 4 compartments. The lumped
parameter model (LPM) is used to produce the waveforms for the boundary conditions and to
determine the cardiovascular output of the system as well as the pressures and flow rates at every
node in the circuit.

Figure 16 RLC representation for atrial and venous beds.
As shown in Figure 16, the resistance, R [mmHg-s/ml], stimulates the resistance the blood
encounter as it flows through the blood vessels, and it depends on the length and the cross-section
area. The capacitor, C[𝑚𝑚𝑚𝑚/𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚], accounts for the dynamic vascular compliance (expanding
and contracting), and the inductor, L [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑠𝑠 2 /𝑚𝑚𝑚𝑚] to account for the inertial effect of the flow.

Finally, a diode is utilized to model the heart valves to ensure unidirectional flow from the heart.
In some parts of the circulatory system where small capillaries and vessels present, capacitors or
inductors can be ignored because other forces have a stronger influence. That would simplify the
calculations and reduce the computation cost. On the other hand, the resistors cannot be neglected
for small vessels as it depends on the vessel geometry and the friction losses. Figure 14 shows the
hydraulic analogy.
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Figure 17 Hydraulic Analogy
To mimic the heart function, a time-varying capacitor that acts as a pumping heart is
introduced to provide a pulsatile cardiac output, as shown in Figure 15. The elastance function En
(𝑡𝑡𝑛𝑛 ), which relates the pressure and volume of the cardiac cycle, is the inverse of the capacitance.

Based on previous studies [157, 158], the “double hill” elastance function is

𝐸𝐸 (𝑡𝑡) = (𝐸𝐸𝑚𝑚𝑚𝑚𝑚𝑚 − 𝐸𝐸𝑚𝑚𝑚𝑚𝑚𝑚 )𝐸𝐸𝑛𝑛 (𝑡𝑡𝑛𝑛 ) + 𝐸𝐸𝑚𝑚𝑚𝑚𝑚𝑚

𝐸𝐸𝑛𝑛 (𝑡𝑡𝑛𝑛 ) = �
𝑡𝑡𝑛𝑛 =

𝑡𝑡

𝑡𝑡𝑐𝑐

1.32
𝑡𝑡
� 𝑛𝑛 �

0.303
1.32
𝑡𝑡
1+� 𝑛𝑛 �
0.303

⋯ 𝑡𝑡𝑐𝑐 =

60

𝐻𝐻𝐻𝐻

��

1

121.9
𝑡𝑡
1+� 𝑛𝑛 �
0.508

�

⋯ 𝐻𝐻𝐻𝐻 = 𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅

(1)

(2)

(3)

Where(𝐸𝐸𝑚𝑚𝑚𝑚𝑚𝑚 ) and (𝐸𝐸𝑚𝑚𝑚𝑚𝑚𝑚 ) represent the end-systolic pressure-volume relationship and the

end-diastolic pressure-volume relationship, respectively. 𝑡𝑡𝑛𝑛 is the normalized time by a time
constant 𝑡𝑡 𝑐𝑐 .

38

Figure 18 Elastance function waveform

Figure 19 Heart Chambers Electrical Bed
The LPM is a closed system, which means all beds interact with each other, and to obtain
the differential equations of the HCS II circulatory system, Kirchhoff node and loop laws
(Equations 4, 5) were used along with the hydraulic analogies. Kirchhoff laws state that the current
entering a junction or a node is equal to the current exit it, and the sum of voltages in a closed-loop
has to be zero.
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𝑦𝑦𝑖𝑖−1 = 𝐶𝐶

𝑑𝑑𝑦𝑦𝑖𝑖
𝑑𝑑𝑑𝑑

+ 𝑦𝑦𝑖𝑖+1 →

𝑦𝑦𝑖𝑖 = 𝑦𝑦𝑖𝑖+2 + 𝑅𝑅𝑦𝑦𝑖𝑖+1 + 𝐿𝐿

𝑑𝑑𝑑𝑑𝑖𝑖

𝑑𝑑𝑑𝑑𝑖𝑖+1
𝑑𝑑𝑑𝑑

1

=

𝑑𝑑𝑑𝑑

𝐶𝐶

[𝑦𝑦𝑖𝑖−1 − 𝑦𝑦𝑖𝑖+1 ]

𝑑𝑑𝑑𝑑𝑖𝑖+1

→

𝑑𝑑𝑑𝑑

=

1
𝐿𝐿

[𝑦𝑦𝑖𝑖 − 𝑅𝑅𝑦𝑦𝑖𝑖+1 − 𝑦𝑦𝑖𝑖+2 ]

(4)

(5)

Both the voltage (pressure) and the current (mass flowrate) were labeled ‘y’ for
consistency. Equations 4 and 5 can be applied to obtain the rest of the ODEs equations that
represent the circulatory system.

Figure 20 Schematic relate equations 4 and 5 to calculate y
Based on Figure 20, the current flows in from the left side and charges the capacitor first.
Then the current will experience a drop in voltage at the resistor and at the inductor due to current
change. The pressure drop is given by Δ𝑃𝑃 = 𝑙𝑙

𝐶𝐶

𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑

𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑

+ 𝑅𝑅𝑅𝑅 and the flow rate across compliance is 𝑄𝑄 =

and by applying Kirchhoff loop and node laws for the heart, the systemic system, the

pulmonary system, and the coronary system, we were able to represent the circuit as a set of ODE.
∆𝑝𝑝 = 𝐿𝐿

𝑑𝑑𝑑𝑑
+ 𝑅𝑅𝑅𝑅
𝑑𝑑𝑑𝑑

𝑄𝑄 = 𝐶𝐶

𝐶𝐶 =

𝑑𝑑(∆𝑝𝑝)
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
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(6)
(7)
(8)

Where Q is the flow-rate, Δp is the pressure difference, and V is the volume. The result of
performing this equilibrium equation at each node a system of coupled 34 ordinary differential
equations that are solved using 4th order adaptive Runge-Kutta methods. The solver requires
besides the ODEs, initial conditions for each pressure and flow rate equation, error tolerance, and
the number of time steps to produce the desired number of heart cycles that can be used as BCs
for the CFD solver. Mathcad (2015 PTC Inc.MA, USA) was used first to tune and validate the
model, and then the C++ programming language was utilized since it executes computations
considerably faster. The baseline values of R, L, and C are tuned to obtain the desired waveforms.
Bed resistance values usually are tuned first as it the primary control of the total flow in any vessel.
Then compliance and inductance values were tuned to obtain the desired waveforms [87, 112,
113]. In total, 12 BCs were generated from the C++ code, and then as mentioned earlier, the
waveforms obtained are compared with the waveforms we received from Arnold Palmer hospital
for the post-operative patient for validation. In summary, the 3-D problem of modeling the whole
circulation system of HCS II patient was reduced to a 34 degree of freedom (DOF) 0-D problem
that can be used to represent any patient underwent HCS II.
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Figure 21 Multiscale model of the HCS II circulation, three-dimensional CFD model, coupled
with the lumped parameter model
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Figure 22 Detailed LPM schematic.
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The target for the cardiac output is 2.99 L/min, 60% of which goes to the lower body
through the pulmonary trunk, and 40 % flows through the ascending aorta to provide blood to the
upper body. The average target pressure for the right ventricle, aortic root, descending aorta,
superior vena cava, and left and right pulmonary artery were 65, 65, 54, 9, and 8 mmHg,
respectively.
In the LPM, two non-linear resistance models are now discussed. The first is the coronary
bed resistance model adapted from [74, 88]. The coronaries supply the myocardium with oxygenrich blood, and then the cardiac veins return the deoxygenated blood to the right atrium. The
coronaries experience high pressure from the ventricle when contracting (systole). As a result,
most of the blood perfusion through the coronaries takes place during diastole. The coronaries can
be modeled based on the elastance function in the LPM to capture the flow during diastole.

2

𝐸𝐸𝑙𝑙𝑙𝑙 (𝑡𝑡)
𝑅𝑅𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 (𝑡𝑡) = �1.75 ∗ ��
�� + 6.796� ∗ 𝑅𝑅𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓_𝑐𝑐𝑐𝑐𝑐𝑐
𝐸𝐸𝑙𝑙𝑙𝑙 (0)

(9)

Where 𝑅𝑅𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓_𝑐𝑐𝑐𝑐𝑐𝑐 can be used to tune the model.

3.4.1 Ventricular Septal Defect
The second resistance modeled in this problem is the non-linear resistance across the
ventricular septal defect (VSD) that appears in the circuit Figure 22 between the inlet to the
pulmonary trunk and the inlet to the ascending aorta. The VSD doesn’t appear in the CFD domain,
but it is represented in the LPM, where R_aorta expresses a flow-dependent non-linear resistance,
typical of an orifice.
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From the Bernoulli equation, it is simple to obtain a relationship for the mass flow rate
across the orifice as
𝑚𝑚̇ =

̇ 𝑉𝑉𝑉𝑉𝑉𝑉
𝐾𝐾𝐴𝐴

�1 − 𝛽𝛽4

( 10 )

�2𝜌𝜌∆𝑃𝑃𝑉𝑉𝑉𝑉𝑉𝑉

where β is the diameter ratio of the orifice and the right ventricle diameter, and к is a loss
coefficient, 𝐴𝐴𝑉𝑉𝑉𝑉𝑉𝑉 and Δ𝑃𝑃𝑉𝑉𝑉𝑉𝑉𝑉 are the area of the orifice and the pressure difference across the defect
[159]

𝐾𝐾 = 0.5959 + 0.0312𝛽𝛽1.2 − 0.184𝛽𝛽8 +

91.71𝛽𝛽2.5
0.75
𝑅𝑅𝑅𝑅𝐷𝐷𝐷𝐷

( 11 )

with 𝑅𝑅𝑅𝑅𝐷𝐷1 The Reynold number based on the right ventricle nominal diameter. Moreover, by

observing a magnitude β to be less than one, к equation can be simplified to к=0.5959.

The pressure drop across the circulatory circuit segment containing the septal defect can be
represented by ∆𝑃𝑃(𝑡𝑡) = 𝐶𝐶𝑄𝑄̇(𝑡𝑡)2 which leads to a nonlinear resistance in terms of volumetric flow

rate 𝑅𝑅�𝑄𝑄̇� = 𝐶𝐶𝑄𝑄̇ (𝑡𝑡) [29, 110, 160-162]. Equation 10 can be rewritten to determine an expression
for resistance to be included in the LPM equations as

𝑅𝑅𝑉𝑉𝑉𝑉𝑉𝑉 �𝑄𝑄̇� =

𝑄𝑄̇𝜌𝜌
266.64(10002 𝐾𝐾𝐴𝐴𝑉𝑉𝑉𝑉𝑉𝑉 )2

( 12 )

The flow rate equation (12) can be more simplified. In addition to this resistance, we add a linear
resistor to represent a portion of the aortic root in conjunction with the atrophied left ventricle
traversed by the flow.
𝑅𝑅𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑄𝑄) = 𝑅𝑅𝑉𝑉𝑉𝑉𝑉𝑉 +

𝑄𝑄
266.64 (10002 𝑘𝑘 𝐴𝐴𝑉𝑉𝑉𝑉𝑉𝑉 )2

Where, 𝑅𝑅𝑉𝑉𝑉𝑉𝑉𝑉 is a linear resistor that can be tuned to obtain the right flow and pressure.
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( 13 )

3.5 Coupling
The principle behind the coupling scheme between the 0D lumped parameter model and
the 3D computational fluid dynamics (CFD) model is to take the whole circulatory system into
account when evaluating a hemodynamic of a specific region. CFD coupled with Lumped
Parameter Models (LPM) has been utilized to tackle numerous hemodynamic circulations.
Quarteroni [163, 164] derived a method to solve these multi-scale models using a mathematical
model. This model followed an iterative structure which had the lumped parameter model leading
the CFD in time. Moreover, Quarteroni and his team focused on the Neumann boundary condition
setup, in which the calculated pressures are transferred over to the CFD on all outlets and inlets.
Esmaily-Moghadam [165] goes even further by incorporating more coupling boundary
conditions such as the Dirichlet, Neumann, and mixed. In the Dirichlet approach, mass flows are
applied to all the outlets and inlets in the CFD model. Whereas the mixed approach applies pressure
as well as mass flows to the outlets and inlets. As a result of the assumptions made to the velocity
profile, the Dirichlet approach losses information. However, it is the least computationally costly
of the two. By modeling the LPM to receive pressures at inductors and flows at capacitors, they
were able to achieve interface stability.
Different coupling boundary condition schemes (Dirichlet, Neumann, and mixed) can be
implemented, as mentioned earlier, between the 3D CFD and the 0D LPM to achieve convergence.
The Neumann approach feeds pressure to the LPM while the Dirichlet transfer mass flows to all
the CFD boundaries. The mixed approach refers to feeding pressure and flows to the LPM for the
same model [165]. The interaction ( coupling) in this study between the CFD and the LPM was at
the heart cycle level “Loose coupling,” which was utilized in previous studies [73, 74]. The process
starts by first constructing and then tuning the nominal LPM to obtain the clinical waveforms of
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pressure and flow provided by Arnold Palmer Hospital. A converged solution using the loose
coupling can be achieved by (1) tuning the HCS II circuit to obtain the desired boundary
conditions waveforms for an HCS II patients, (2) impose stagnation pressure for the inlet
boundaries and flow rate for the outlets (SVC,RPA,LPA,RCORA,LCORA,LAS,LCA,RCA,RSA
and DA) using the initial tuned data from the LPM, (3) run the CFD for a complete 3-heart cycles
to obtain flow solution, (4) update the CFD resistance for the area of interest within the LPM (5)
Impose the new boundary conditions values after running the LPM, (6) keep iterating until a
converged solution is obtained . Updating the resistance for the area of interest can be done by
measuring pressure and mass flow rate at each section of the geometry in corresponding to the 0D
circuit nodes and segments. The surface averaged mass flow and pressure are then time-averaged
over the cycle. Furthermore, the obtained results are used to update the resistance based on Ohm’s
law. Finally, the new flow and pressure boundaries are imposed on the CFD solver after the LPM
converges. The user carries on this process, which usually takes about 15-20 runs to achieve
convergence. The coupling steps can be automated by using a java macro that handles feeding the
BCs to the CFD solver and returns the new updated resistance values to the RK solver. The
convergence criteria are set so that the change in the flow in all branches is less than 10−3 or
resistor values no longer change across when iterate. Usually, the CFD is run for three more cycles

after convergence achieves a sustained periodic solution and then post-processing starts.
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Figure 23 Coupling scheme
3.6 Discretization
The next step, after importing the geometry to the CFD solver, is to divide the
computational domain into small finite elements or cells, i.e., mesh. Discretization in most CFD
software is automated, but manual refinement is needed for complicated geometries.
Moreover, different mesh methods are available: finite volume method, finite element
method, finite difference method, and meshless method and the mesh technique used in any study
depends on the CFD software. A high-quality mesh was generated using tetrahedral elements,
which is considered more practical for complex geometries[166], with a base size of 0.3 mm along
with 3-prism layers near walls to capture the boundary layer flow. STAR-CCM+ (Siemens), which
is a commercial computational fluid dynamic solver was used in this study, allows users to control
prism layer can be by: (1) layer total thickness, (2) number of prism layers, (3) layer stretching.
Customization and refinement of the mesh were used in this study because the model has a
different range of diameters as well as non-uniform vessels, specifically the area over the baffle.
The customized tool allows users, for example, to control the number of are generated in a
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specified area or change the base size. The number of cells varied between 1.5 and 2.3 million
depending on the anatomy, as shown in Table 5.
Mesh independence study was carried out to find the required mesh density for the solution
to converge by measuring the changes in the computational results of the fine and the finer grids.
That was done by running the simulation in a steady-state and monitor the pressure at the inlets
and the flow rate at the outlets. In this study, 3-different levels of refinement carried out, and
percentage errors were evaluated. The mass flow rate and the pressure were calculated at different
locations (RPA root, SVC, RPA, DA, AO, and LPA). Table 3 and Table 4 show the flow rate and
pressure at a different location with different mesh refinement. The +20% model percentage errors
were ranging between 0.0 -0.15 % for the majority of the quantities evaluated.
Table 3 Mesh independent study
Case 1
(Baseline)
Cell count

Fine (+20%)

Coarse (20%)

Percentage change

1344341

1604514

1079184

Fine

Coarse

0.0226

0.0226

0.0226

0.0

0.0

SVC flowrate [Kg/s]

0.01566

0.01566

0.01566

0.0

0.0

RPA flowrate [Kg/s]

0.00716

0.00715

0.00715

0.14

0.14

DA flowrate [Kg/s]

0.0144

0.0144

0.0144

0.0

0.0

LCA flowrate [Kg/s]

0.00407

0.0407

0.0406

0.0

0.25

Aorta flowrate [Kg/s]

0.009119

0.00911

0.009114

0.099

0.055

LPA flowrate [Kg/s]

0.0085

0.0085

0.00851

0.0

0.12

PA root flowrate
[Kg/s]
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Table 4 Mesh independent study
Case 1
(Baseline)

Fine (+20%)

Coarse (20%)

Percentage change

Cell count

1344341

1604514

1079184

Fine

Coarse

PA root pressure [Pa]

9368

9368

9368

0.0

0.0

SVC pressure [Pa]

25

26

16

4.0

36.0

RPA pressure [Pa]

14

14

5

0.0

64.29

DA pressure [Pa]

8571

8558

8575

0.15

0.047

LCA pressure [Pa]

5253

5001

5455

4.80

3.85

Aorta pressure [Pa]

5950

5708

6150

4.07

3.36

LPA pressure [Pa]

-22

-22

-30

0.0

36.36

As can be seen in the table above, the flow and pressure analysis for the baseline case and
the +20%, which has a finer mesh, are consistent.
One of this study's aims was to investigate the pressure drop across the baffle by varying
the area over the baffle. Another aim was to determine the limits of the aorta diameters that
assure adequate cerebral blood flow. Table 5 shows the number of cells of three different
geometries used in this study as the area over the baffle increases, and as the aortic root diameter
increases.
Table 5 (Left) number of cells for models as the area over the baffle increases, (Right) as the
aorta size increases
Model

Cells Count
(million)

Model

Cells Count
(million)

Case1

2.1

Case1

2.3

Case2

2.3

Case2

2.7

Case3

2.5

Case3

2.8
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Figure 24 (Left) Meshed geometry, (Right) meshed ascending aorta inlet
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3.7 Computational Fluid Dynamics (CFD)
The patient-specific model constructed from CT scan image and the synthetic models built
in SolidWorks is imported into StarCCM+, which is a commercial finite volume multi-scale
computational fluid dynamics solver developed by SIEMENS. StarCCM+ is used to solve
numerically the continuity equation and Navier-Stokes equations, which describes the blood
motion in the three spatial dimensions.

�⃗ = 0
∇ ∙ 𝑉𝑉

ρ

�⃗
𝜕𝜕𝑉𝑉
���⃗ ∇�𝑉𝑉
���⃗ = −∇p + ∇. σ
+ ρ�𝑉𝑉.
𝜕𝜕𝜕𝜕

( 15 )
( 14 )

�⃗ is the velocity, σ is the viscous stress tensor, and p is the pressure.
Where, 𝑉𝑉

Figure 25 Three separate fluid regions, Systemic flow (left) and Pulmonary flow (middle)
and Aortic flow (right)with 100% stenosis
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This study assumes:
1. The space is three dimensional.
2. Laminar flow
3. Incompressible fluid
4. Rigid walls
5. Non-Newtonian
6. For completeness, the gravity force is considered.
The blood was considered as a non-Newtonian shear-thinning fluid, where the viscosity is
inversely proportional to the shear rates. Hematocrit, which is the ratio of red blood cells to the
total volume of the blood, controls the blood viscosity, as shown in Figure 26.

Figure 26 Relationship between hematocrit and viscosity [167]
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The Carreau-Yasuda model was used in this numerical study to specify the non-Newtonian
behavior of the blood.
𝜇𝜇(𝛾𝛾̇ ) = 𝜇𝜇∞ + (𝜇𝜇𝑜𝑜 − 𝜇𝜇∞ )

[1 +

1

( 16 )

1
(λ𝛾𝛾̇ )2 ]3

Where 𝜇𝜇𝑜𝑜 is the zero-shear viscosity, 𝜇𝜇∞ is the infinite-shear viscosity, λ is the relaxation time
constant and 𝛾𝛾̇ is the shear rate. Using this model, the viscous stress tensor is expressed as
( 17 )

�����⃗𝑇𝑇 �
�⃗ + ∇𝑉𝑉
σ = μ(𝛾𝛾̇ ) �∇𝑉𝑉

Table 6 shows model constants for different hematocrit levels (20%, 40%, and 60%) which were
obtained by curve fitting clinical data [168]
Table 6 Tabulated value for Carreau-Yasuda model constants
Hematocrit [%]

20

𝜇𝜇∞ [cP]

𝜇𝜇𝑜𝑜 [cP]

λ [s]

2.7459

3.5832

-2.783

40

4.3989

8.4248

0.3103

60

7.0151

19.8035

0.2646

The governing equations were solved in StarCCM+ using the unsteady implicit solver with
a second-order time discretization and second-order upwinding of the convective derivatives. The
boundary conditions imposed: a stagnation inlet at the pulmonary artery (PA) and mass flow rates
inlet and an outlet for the rest (SVC, RPA, LPA, RCORA, LCORA, RCA, RSA, LCA, and LSA).
All the boundary conditions are calculated using the 0D lumped parameter model. The wall was
modeled as a rigid and non-permeable wall for simplicity and computation cost reduction.
Moreover, the segregated solver was chosen in this study to solve the mass equation and the
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momentum equations subsequently, and as mentioned earlier, the second-order upwinding scheme
was used to discretize the momentum convection terms. Furthermore, the time step used in this
simulation is 0.005 seconds based on calculating the Courant number, which should be about one
to obtain time-accurate solutions. The Courant number was calculated from equation (18).

𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 =

𝑢𝑢∆𝑡𝑡
∆𝑥𝑥

( 18 )

Where 𝑢𝑢 = 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣,∆𝑡𝑡 = 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 and ∆𝑥𝑥 = 𝑚𝑚𝑚𝑚𝑚𝑚ℎ 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠.

Based on the volumetric flow rate, we calculated the flow velocity. Then by back-

calculation, the time step based on mesh size used to discretize the geometry. All the computations
were performed using Caesar, Newton, and Stokes computer clusters at the University of Central
Florida.
After imposing the initial BCs from the LPM, the CFD solver will run until reaching the
physical time set by the user (1.5 seconds in this case). Then, the mass flow rate and pressure are
calculated and time-averaged to determine the new resistance by
𝑃𝑃𝑖𝑖 − 𝑃𝑃𝑖𝑖+1
𝑅𝑅 =
𝑚𝑚̇𝑖𝑖

( 19 )

The above equation is applied to all the cross-sections shown in Figure 27, which each represents

a node in the 0D lumped parameter model. The coupling scheme as explained in section 3.5, will
be carried out using the newly calculated resistance to run the LPM and update the CFD BCs until
a converged solution obtained.
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Figure 27 Fluid domain locations to calculate flow rate and pressure

3.8 Oxygen Transport Model
Based on the oxygen consumption in the systemic circulation, the oxygen uptake in the
pulmonary circulation, and conservation equations, the oxygen model equations were derived for
the HCS II procedure. The major parameter that affects the oxygen content is the flow split
between the systemic and the pulmonary flow. In the HCS II model, the right ventricle flow is
distributed to the lower body circulation and the upper body circulation. The venous blood from
the lower circulation flows back through the inferior vena cava (IVC) to the right atrium while the
upper body deoxygenated blood flows back to the pulmonary arteries through the superior vena
cava (SVC) and that leads to two parallel flows as shown in Figure 28.
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With reference to Figure 28 that shows the circulation model of HCS II, the oxygen
transport equations were derived as follows
𝐶𝐶𝑉𝑉̇𝑂𝑂2 = 𝑥𝑥 𝐶𝐶𝑉𝑉̇𝑂𝑂2 + (1 − 𝑥𝑥)𝐶𝐶𝑉𝑉̇𝑂𝑂2

( 20 )

The upper and lower body splits the oxygen consumed in every cardiac cycle, and 𝑥𝑥

̇ ) as shown in equation (20)
represents the oxygen portion the upper body consumes (𝑥𝑥 𝐶𝐶𝑉𝑉𝑂𝑂2
𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝑈𝑈 − 𝑥𝑥 𝐶𝐶𝑉𝑉̇𝑂𝑂2 + 𝑆𝑆𝑉𝑉̇𝑂𝑂2 = 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝑈𝑈

( 21 )

Equation (21) states that the upper circulation venous oxygen flow rate (𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 *𝑄𝑄𝑈𝑈 )

returning to the heart from the lungs is equal to the oxygen flow rate into the upper systemic

circulation (𝐶𝐶𝑆𝑆𝑆𝑆2 *𝑄𝑄𝑈𝑈 ) plus the oxygen uptake in the lungs reduced by the oxygen consumed by
the upper body (𝑥𝑥 𝐶𝐶𝐶𝐶𝑂𝑂2 ).

𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿 − (1 − 𝑥𝑥 )𝐶𝐶𝑉𝑉̇𝑂𝑂2 = 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿

( 22 )

For the lower body circulation, equation (22) states that the product of subtracting the
̇ ) from the systemic oxygen flow rate into the
oxygen consumed by the lower body ((1 − 𝑥𝑥 )𝐶𝐶𝑉𝑉𝑂𝑂2

lower body ( 𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿 ) is equal to the oxygen flow rate returning to the heart from the lower

circulation (𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿 ).

The relation between the upper and lower circulation to the cardiac output of the systems is shown

in equation (23)
𝑄𝑄𝑈𝑈 + 𝑄𝑄𝐿𝐿 = 𝐶𝐶𝐶𝐶

( 23 )

Equation (23) states that according to the mass conservation law, the oxygen uptake in the
lungs is equal to the oxygen consumed by the body.
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From equation (22)

𝑆𝑆𝑉𝑉̇𝑂𝑂2 = 𝑥𝑥 𝐶𝐶𝑉𝑉̇𝑂𝑂2 + (1 − 𝑥𝑥) 𝐶𝐶𝑉𝑉̇𝑂𝑂2

𝐶𝐶𝑆𝑆𝑆𝑆2 =

𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿 + (1 − 𝑥𝑥 )𝐶𝐶𝐶𝐶𝑂𝑂2
𝑄𝑄𝐿𝐿

and by replacing 𝐶𝐶𝑆𝑆𝑆𝑆2 in (21) we obtain
𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2

𝑄𝑄
̇
𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 ∗ 𝑄𝑄𝑈𝑈 − 𝑄𝑄𝑈𝑈 (1 − 𝑥𝑥 )𝐶𝐶𝑉𝑉̇𝑂𝑂2 + 𝑥𝑥 𝐶𝐶𝑉𝑉̇𝑂𝑂2 − 𝑆𝑆𝑉𝑉𝑂𝑂2
𝐿𝐿
=
𝑄𝑄𝑈𝑈

( 24 )

( 25 )

( 26 )

From (23) and (24) and (26)

𝑄𝑄𝐿𝐿
𝑄𝑄𝐿𝐿
+ 1)𝑥𝑥 𝐶𝐶𝑉𝑉̇𝑂𝑂2 − (
+ 1)𝑆𝑆𝑉𝑉̇𝑂𝑂2
𝑄𝑄𝑈𝑈
𝑄𝑄𝑈𝑈

( 27 )

𝑄𝑄𝐿𝐿
+ 1)(1 − 𝑥𝑥)𝐶𝐶𝑉𝑉̇𝑂𝑂2
𝑄𝑄𝑈𝑈

( 28 )

𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝐶𝐶𝐶𝐶 = 𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 ∗ 𝐶𝐶𝐶𝐶 + (

𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝐶𝐶𝐶𝐶 = 𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 ∗ 𝐶𝐶𝐶𝐶 − (

Figure 28 Oxygen transport model for HCS II
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Another oxygen model was constructed for the HCS II, but in this case, the split ratio
between the upper and lower circulation was ignored.
In this case, the same analysis used with the first model was utilized to derive the oxygen model
equations as follows
𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝐶𝐶𝐶𝐶 − 𝐶𝐶𝑉𝑉̇𝑂𝑂2 = 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝑈𝑈 + 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝐿𝐿

( 29 )

Equation (29) states that the systemic oxygen flow into the body ( 𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝐶𝐶𝐶𝐶) is reduced

by the whole body consumption (𝐶𝐶𝑉𝑉̇𝑂𝑂2 ) leaving the returned oxygen flow to the heart.
𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 ∗ 𝑄𝑄𝑈𝑈 + 𝑆𝑆𝑉𝑉̇𝑂𝑂2 = 𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 ∗ 𝑄𝑄𝑈𝑈

( 30 )

Equation (30) states that the sum of the oxygen uptake in the lungs (𝑆𝑆𝑆𝑆𝑂𝑂2 ) SVO2 for our

model and the oxygen flow rate into the pulmonary circulation (𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 *𝑄𝑄𝑈𝑈 ) gives the oxygen flow
rate into the pulmonary veins.

From equation (30)

𝑆𝑆𝑉𝑉̇𝑂𝑂2 = 𝐶𝐶𝑉𝑉̇𝑂𝑂2

( 31 )

𝑄𝑄𝑈𝑈 + 𝑄𝑄𝐿𝐿 = 𝐶𝐶𝐶𝐶

( 32 )

𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 =

𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 ∗ 𝑄𝑄𝑈𝑈 − 𝑆𝑆𝑉𝑉̇𝑂𝑂2
𝑄𝑄𝑈𝑈

By substitute 𝐶𝐶𝑆𝑆𝑆𝑆𝑆𝑆2 in equation (29) and using equation (30) and (31)
𝐶𝐶𝑆𝑆𝑆𝑆2 ∗ 𝐶𝐶𝐶𝐶 = 𝐶𝐶𝐶𝐶 ∗ 𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃2 −
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1
𝐶𝐶𝑉𝑉̇𝑂𝑂2
𝑄𝑄𝑈𝑈
𝑄𝑄𝐿𝐿

( 33 )

( 34 )

Figure 29 Oxygen transport model without flow split
3.9 Hemodynamic Parameters
After obtaining satisfactory solutions (flow and pressure), more quantities are examined in this
study including, the energy loss (EL) of the flow, the wall shear stress (WSS), and the velocity
vectors.
The energy loss can be calculated in two methods: the dissipation function method, which
attributes all the energy loss to viscous force (friction) for laminar flow, and the control volume
approach, which is used in this study.

( 35 )

𝐸𝐸𝐸𝐸 = 𝐸𝐸𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 − 𝐸𝐸𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂
𝐸𝐸𝐿𝐿 =

𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖

�
𝑖𝑖=1

1
���⃗ |2 + 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 )𝑄𝑄 −
( 𝜌𝜌|𝑣𝑣
2

𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
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�
𝑖𝑖=1

1
���⃗ |2 + 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 )𝑄𝑄
( 𝜌𝜌|𝑣𝑣
2

( 36 )

The energy loss used in this study was justified by [39, 40, 169-171], where 𝑄𝑄 represents the blood
flow rate, 𝐴𝐴 is the area at an inlet or an outlet. 𝑃𝑃𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 was computed using Bernoulli’s theorem.

( 37 )

𝑄𝑄 = ���⃗
|𝑣𝑣 |𝐴𝐴

1 2
𝜌𝜌𝑣𝑣 + 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 = 𝑃𝑃𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑎𝑎
2

( 39 )

The inlet is the pulmonary artery (PA) and the outlet is the descending aorta (DA). The energy
efficiency is calculated for each case and it is defined as the ratio between the fluid energy exiting
the model and the energy going into the model.

𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 =

𝐸𝐸𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂
𝐸𝐸𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖

( 38 )

The EL was calculated as a function of split ratio and as a function of the area over the baffle. In
the first study, the coupled multi-scale CFD was run with various flow split ratio between the lower
and the upper body circulations. The nominal 60/40 lower body/upper body split and three more
different split ratios (50/50,55/45,65/35) simulations carried out until a converged solution was
obtained.
The second study requires a geometric manipulation to create 5- synthetic geometries with various
MPA narrowing sizes, measured as the minimum distance between the systemic baffle surface and
the distal pulmonary trunk surface the stricture size was manipulated to build various surgical
baffle as shown in Figure 11 &13 to determine the effect of the baffle size on the energy loss. Both
studies results are reported and plotted in the results section.
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1 𝑇𝑇
𝑊𝑊𝑊𝑊𝑊𝑊 = � � ����⃑
𝜏𝜏 𝑑𝑑𝑑𝑑�
𝑇𝑇 0 𝑤𝑤

( 40 )

WSS magnitude calculated in equation 40 is the time-averaged value of the WSS
magnitude. ����⃑
𝜏𝜏𝑤𝑤 is the wall shear stress tensor. WSS was found to cause platelet activation, red blood
cell damage, and it increases the thrombus risks, as mentioned in the literature section[172-175].

Particle residence time (PRT) was also calculated in this study by randomly releasing
particles and then calculate the residence time of each particle. PRT can help identify regions of
recirculation that can increase the risk of thrombus formation. Higher residence time in a specific
region may cause platelets to accumulate shear stress and become activated [172, 176].
Furthermore, PRT can be calculated by injecting a high number of particles at the inlet or inside
of the region of interest and then tracing the particle locations over time [177-179]. Reininger et
al. [176] calculated residence time to determine the effect of shear stress and residence time on
fibrin clot formation in a laminar and turbulent flow. A simple T-branching model was used in this
study to test the clotting time, quantify the flow separation and calculate the residence time. The
study found that residence time and convergent flow are more critical for clot formation than the
shear rates. Suh et al. [178] used CFD as a tool to calculate the particle residence time (PRT) and
particle residence index of different patient specifics model with aortic aneurysm. About 100,000
particles were injected during the first cardiac cycle, and the PRT and PRI were monitored over
ten cycles. The results showed the importance of using a patient’s specific models since none of
the models showed similar results to the balloon-shaped aneurysm. Moreover, PRT and PRI
calculations were different between patients, and this study demonstrated the importance of PRT
and PRI to identify the recirculation and stagnation zones. Kunov et al.[177]introduced and
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calculated particle volumetric residence time (VRT) which takes into account the accumulating
regions and the time each particle spends. The model was a simple artery (one inlet and one outlet)
with 45% stenosis. The areas with high shear stress and low velocity showed a high PRT.
Moreover, in this study, a concept “platelet activation” was introduced when particles are exposed
to shear stress higher than the critical value. In similar studies PRT calculations were different
between patients and demonstrated the importance of PRT to identify the recirculation and
stagnation zones.
In this study, a Lagrangian scheme was implemented to track the released particles. The
Lagrangian model can also be used to visualize the area of circulation and stagnation and to count
the number of particles (thrombi) that passes through each outlet in the fluid domain, which can
induce clot formation. After obtaining a converged flow field, the Lagrangian tracking scheme was
activated, and particles are injected. The Maxey-Riley particle equation is given by

𝑚𝑚𝑝𝑝

����⃗
𝑑𝑑𝑉𝑉
𝑝𝑝
𝑑𝑑𝑑𝑑

= 𝑚𝑚𝑓𝑓

�����⃗
𝐷𝐷∗𝑈𝑈
𝑓𝑓
𝐷𝐷𝐷𝐷

𝑚𝑚𝑓𝑓
2

�

����⃗𝑓𝑓 − 𝑉𝑉
���⃗
+ (𝑚𝑚𝑝𝑝 -𝑚𝑚𝑓𝑓 )𝑔𝑔⃗ + 6𝜋𝜋𝜋𝜋𝜋𝜋 �𝑈𝑈
𝑝𝑝 +

����⃗
𝑑𝑑𝑉𝑉
𝑝𝑝
𝑑𝑑𝑑𝑑

−

𝐷𝐷

𝐷𝐷𝐷𝐷

2

����⃗𝑓𝑓 + 𝑎𝑎 ∆𝑈𝑈
����⃗𝑓𝑓 ��
�𝑈𝑈

𝑎𝑎2
6

����⃗𝑓𝑓 � +
∆𝑈𝑈

10

Where a is the particle radius; µ fluid viscosity,𝑚𝑚𝑓𝑓 = 𝜌𝜌𝑓𝑓 𝑉𝑉, 𝑚𝑚𝑝𝑝 = 𝜌𝜌𝑓𝑓𝑓𝑓 𝑉𝑉, 𝑉𝑉 is particle volume, 𝜌𝜌𝑓𝑓

is fluid density, 𝜌𝜌𝑝𝑝 is particle density and 𝑔𝑔 is gravity. The right side terms represent the fluid
pressure gradient, the gravity, the drag force and the added mass, respectively.

In order to prevent particles from affecting the converged flow field, zero mass particles
were injected at the MPA inlet. Spherical particles were injected for several cardiac cycles using
injection grids at the MPA inlet, as shown in Figure 30. This study aims to investigate the area
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where the pulmonary arteries stent placed. The high-pressure blood from the ventricle flow over a
half-cylindrical shaped vessel that may lead to flow circulation due to pressure drop.

Figure 30 MPA: main pulmonary artery injection grid
A high number of particles were released at each run to obtain a spatial distribution, with
the initial velocity set to be zero. Moreover, the release of particles from each node of the grid
was controlled by point inclusion probability function built-in STARCCM+. Excel was used to
generate a table bounded by 0 and 1 to randomize the particle release time. The simulation was
set to continuously release particles over time for several runs because PRT depends on the
release time. Also, a particle tracking counter was set at each boundary in the fluid domain to
calculate how many particles leaving from each outlet.
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CHAPTER FOUR:
RESULTS AND DISCUSSION
Mesh Independence Study
The post-processing and the data visualization was carried out after obtaining a sustained
flow and pressure solutions. The CFD results must be independent of the mesh used in the study.
Thus, a mesh independence study was carried out with different meshes while monitoring the flow
and pressure at the inlets and the outlets of the boundaries. The results of this study are shown in
Table 3 and Table 4 for 3-different mesh refinements and the percentage error.

Lumped Parameter Model (LPM)
The LMP for HCS II consists of 5 subsystems (the heart, the upper circulation, the lower
circulation, the coronaries, and the pulmonary circulation), and each consists of multiple
compartments (arterial and venous). The LPM was tuned to produce the desired waveforms as
boundary conditions to the CFD. In this case, a 6-months old patient with a cardiac output of about
3 (L/min) with a cardiac cycle of 0.5(s). Traditionally HLHS has atrophied aortic root where no or
little flow output through the left part of the heart. But that is not the case for applicable HCS II
patients who have a ventricular septal defect allowing a sufficient amount of blood flow through
the aortic root. The LPM was tuned to a 60/40 inflow split and 70/30 split between the MPA
supplying the lower circulation and the AA feeding the upper circulation and the left and the right
coronary arteries, respectively. The converged boundary conditions plots from the LPM are shown
in Figure 32. Also, to validate the LPM results after tuning, the waveforms obtained from the LPM
of the heart pressure were compared to the catheter plots provided by Arnold Palme Hospital. For
example, a similar magnitude and features are noticed when comparing the MPA pressure plot and
the catheter pressure waveform for the MPA as shown in Figure 33.
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Figure 31 Pressure waveforms
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Figure 32 Sample BC waveforms for all inlets and outlets (AORTA=Aortic Root, SVC=Superior
Vena Cava, DA=Descending Aorta, RPA=Right Pulmonary Artery, LPA=Left Pulmonary
Artery, LcorA=Left Coronary Artery, RcorA=Right Coronary Artery, LCA=Left Carotid Artery,
RCA=R
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Figure 33 BCs waveforms (top) De-identified main pulmonary artery (bottom) tuned LPM MPA
pressure
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Figure 34 Tuned Aorta pressure (Left) De-identified data from APH,(Right) tuned LPM pressure
Multi-Scale Model Convergence
A stable solution was successfully obtained for all the different CFD models. The coupling
procedure, as mentioned in section 3.5, was run until a converged solution was reached. The
number of iteration required was ranging between 15-25 iterations based on the geometry and the
flow fields. Figure 36 displays the flow rate measured at the main pulmonary artery cross-section
at each iteration (as an example). This procedure was conducted for each cross-section showed in
Figure 24 to check for convergence, which can be achieved by reaching a sustained flow field.
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Figure 35 MPA cross-section

Figure 36 MPA averaged flowrate per iteration
Figure 36 shows the flow rate at each iteration with about 1.5 million mesh cells, where 3heart cycles take about 20 hours, employing 32 CPUs. The figure shows a negligible change in
the flow field starting at the 6th iteration.
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Systemic pressure drop
The presence of the baffle in the pulmonary trunk mandates further elucidation of the
relationship between the baffle-related narrowing and the pressure drop across the main pulmonary
artery. This requires two examinations: first, we want to isolate how the protruding baffle affects
the flow field. Second, it is of interest to quantify the combined effect of the pulmonary trunk
restriction and subsequent distal arch “kink.” The geometry shown in Figure 10 can easily be
manipulated to investigate various MPA narrowing sizes, measured as the minimum distance
between the systemic baffle surface and the distal pulmonary trunk surface (Figure 37). Table 7
offers an overview of all the measurements carried out for the various narrowing increments.
Average values are computed as surface-averaged pressures over the sampling surface, which are
then time-averaged, while peak values are the maximum values observed across the sampling
surface throughout a single heart cycle.

Figure 37 Location of the MPA lumen defining MPA narrowing characteristic height (H)
As shown in Figure 38, we sampled pressure data relative to stricture before, PA, and after
the baffle, PB, for various obstruction levels. A similar approach was applied to monitor the
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pressure in the distal arch. The purpose of these pressure measurements was to ensure that any
level of obstruction considered in this and future studies would not exceed a clinically accepted
pressure drop of 10 mmHg. In addition, we were able to visualize a wider array of hemodynamics
and observe how strongly the baffle affects the downstream flow regime. Figure 38 (presented as
the absolute pressure difference between pressure proximal and distal to the baffle, (Δp=PA-PB)
shows how the peak ∆p is strongly affected by the incrementally large obstruction of the flow,
while the surface averaged ∆p experience little change.

Figure 38 Time-averaged peak and surface averaged pressure drop across the baffle (top), and
time-averaged peak and surface averaged pressure drop from baffle to distal arch (bottom) with
respect to obstruction size.
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Similar observations are made for the pressure difference between proximal to the baffle
and the distal arch. The peak pressures clearly display a change, while the average pressure does
not undergo significant variation. Of great relevance, however, is the magnitude change of the
pressure drop for the peak pressures between the first and second plots. Across the baffle, the
largest pressure drop was 2.96 mmHg, while for the same narrowing size and accounting for the
distal arch kink, a four-fold increase is observed yielding a 12.15 mmHg drop. The largest pressure
drop measured is 14.95 mmHg, which, interestingly, did not occur at the narrowest obstruction
size. While the trend observed when isolating the baffle effect was expected, the trend displayed
in the pressure drop to the distal arch could be counterintuitive. When accounting for the distal
arch contribution, the peak pressure difference shows a mild upward slope, indicating that for
increasing MPA narrowing an increased pressure drop is observed. This can be explained by how
the geometry in the pulmonary trunk is implemented and modified. As the diameter of the
narrowing is incrementally increased, then the pulmonary trunk is geometrically inflated,
corresponding to a larger patch of the MPA. This means that proximal to the baffle, the right
ventricular flow will see an incremental increase volume. For a rigid wall model, this additional
volume creates a region that acts similarly to a reservoir, causing a mild build up in pressure. In
order to meet physiological flow rates, an increased pressure drop is required.
Despite the increased peak pressure drop observed, our model predicts that the current
geometrical implementations fall within the predetermined clinical thresholds.
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Table 7 - Surface averaged, and peak pressures drop for incremental pulmonary trunk
narrowing sizes.
PA trunk size

Pressure drop across baffle

Pressure drop from baffle to apex

𝛿𝛿𝑚𝑚𝑚𝑚𝑚𝑚 [𝑚𝑚𝑚𝑚]

𝛿𝛿𝑚𝑚𝑚𝑚𝑚𝑚 [𝑚𝑚𝑚𝑚]

���� [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚]
∆𝑝𝑝

∆𝑝𝑝𝑚𝑚𝑚𝑚𝑚𝑚 [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚]

���� [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚]
∆𝑝𝑝

∆𝑝𝑝𝑚𝑚𝑚𝑚𝑚𝑚 [𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚]

7.71

15.48

0.46

2.53

2.36

12.92

8.19

16.70

0.38

2.14

2.48

13.44

8.66

18.80

0.37

2.11

3.09

16.91

9.09

19.00

0.25

1.40

2.66

14.41

9.52

19.60

0.22

1.25

2.78

14.95

7.23

14.40

0.53

2.96

2.20

12.15

Vortex Formation
In the systemic circulation, the baffle can be thought of as a half-cylinder in cross-flow. A
prime feature of such flow is the von Kármán vortex street caused by an unsteady flow separation
around the cylinder. Vortices downstream from the baffle would be undesirable flow features;
hence it should be determined if vortices may indeed form due to this particular geometry. Around
the area of interest, the free-stream (at the centerline of the conduit) Reynolds number (𝑅𝑅𝑅𝑅) was
computed to be about 1807 (laminar flow, pipe flow transitions at 𝑅𝑅𝑅𝑅 ≅ 2300). The empirical

relation in Equation 41 valid for 𝑅𝑅𝑅𝑅 range 250 < 𝑅𝑅𝑅𝑅 < 2 ∙ 105 is used to calculate the Strouhal

number (𝑆𝑆𝑆𝑆 =

𝑓𝑓𝑓𝑓
𝑈𝑈

), which is a dimensionless number expressing the ratio of the rate of vortex
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shedding frequency (𝑓𝑓) to the main fluid velocity (𝑈𝑈) for a given hydraulic diameter (𝐷𝐷)
characterizing the oscillatory nature of the flow,

𝑆𝑆𝑆𝑆 = 0.198 �1 −

19.7
𝑅𝑅𝑅𝑅

�

(41)

For the computed Reynolds number of around 𝑅𝑅𝑅𝑅 = 1807, the Strouhal number was found

to be 𝑆𝑆𝑆𝑆 = 0.1958. This corresponds to a shedding frequency of 𝑓𝑓 = 6.53 𝐻𝐻𝐻𝐻. Inverting the
frequency, we obtain a period of 0.15 𝑠𝑠. Given the shedding period and the flow velocity, it is

possible to determine the distance required to form and sustain vortices. For an average fluid
velocity of 0.5

𝑚𝑚
𝑠𝑠

, a transport distance is calculated at ~75 𝑚𝑚𝑚𝑚 which is far larger than the distance

from the baffle to the aortic arch apex. This indicates a low probability of significant vortex
propagation, as there would not be enough space for a vortex to form fully, even though when

drawing a parallel between the vortex period to the heart cycle (0.15s < 0.5s), about three vortices
per heart cycle would be generated. Indeed, no vortex shedding from the baffle is observed in the
computational model. This suggests that vortex shedding for the HCS II baffle should not be of
great concern.

Flow Field
In this model, we are studying three separate circulatory regions: two high-pressure
systems driven by the right ventricle and a low-pressure system heading to the pulmonary arteries.
Figure 12 displays the unsteady velocity field the model predicts at four points during the heart
cycle: late diastole, early systole, peak systole, and early diastole.
In the upper-body systemic circulation, left ventricular (LV) output can be readily observed
in systole, characteristic of the HCS II. In diastole, the upper-body circulation experiences very
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mild retrograde flow due to severely weakened pulsatility. Stagnant flow is observed in the aortic
arch apex as well. Coronary flow can be seen at its peak in early/mid diastole (bottom of Figure
39), presenting the characteristic out-of-phase waveform. As expected, the pulmonary flow
presents weak pulsatility compared to the systemic flow. Due to the 90° T-junction shape of the
SVC anastomosis to the pulmonary arteries, flow originating from the SVC impinges on the distal
junction wall. However, due to low flow velocities and lack of pulsatility in the pulmonary
circulation, the branching flow does not present large recirculation or swirling, which could be
seen at higher inflow speeds. Though localized, a combination of rotational flow and impingement
can pose many different issues ranging from intimal hyperplasia to thrombogenesis. As such,
shaping the SVC anastomosis, as is effectively done in the Y-Fontan graft [180], would reduce
such pathologies in the flow. In the pulmonary trunk leading to the distal arch section, the model
can be thought of as a half-cylinder in cross-flow. Figure 40 offers better insight into the flow
acceleration in the geometrical restriction due to the baffle over the cardiac cycle. Since the fluid
is assumed incompressible, a lumen area reduction would promote flow acceleration. Both figures
39-40 display this phenomenon. In addition, as the systolic phase picks up, the flow detaches from
the baffle surface. In diastole, as the ventricular pressure gradient dissipates, the flow re-attaches
to the surface nearly all the way to the baffle suture to the inner aortic arch wall.
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Figure 39 Velocity field representation using streamlines for a second heart cycle.
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Figure 40 Pulmonary truck axial cross-sectional cut with velocity field contour plot.
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Figure 41 displays the pressure field on the same cut plane, as in Figure 40. This image
clearly shows the pressure gradient across the baffle (upstream and downstream). The plot
accompanying the pressure contour plot displays the pressure at point probes placed before (in
green) and after (in red) the baffle. In particular, during systole, the adverse pressure gradient
causes the flow to detach from the baffle. In diastole, due to the absence of right ventricle output
and the anatomical enlargement of the conduit, the pulmonary root region experiences a large
region of recirculation. In addition, this figure highlights the pressure loads experienced by the
underlying stent during systole. The stent, placed beneath the baffle in the pulmonary circulation,
undergoes normal and shear loads throughout the cardiac cycle. It must be emphasized that the
stent perceives a combination of cyclic systemic and pulmonary loading, which could ultimately
lead to mechanical failure. Identifying structural response induced by cyclic fatigue is important
to assess potential issues with stent integrity under these conditions, and is under current
investigation within our group.
The localized pressure increase in the upper section of the contour is caused by the
converging-diverging nozzle (CDN) effect induced by the restriction in the MPA, which becomes
more evident during diastole. These pressure fields can be partially responsible for the flow
reattaching to the baffle surface.

80

Pressure measurements locations

Figure 41 Pulmonary trunk axial cross-sectional cut with pressure field contour plot.
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Baffle Loading and Wall shear Stresses
The main feature of HCS II is the presence of a baffle separating the systemic flow from
the pulmonary flow; therefore, close inspection of the effects of the high-pressure flow on the
baffle surface is important. Figure 42 provides a good insight on wall shear stress (WSS)
distribution on the baffle. In addition, it allows us to observe the location of flow detachment and
re-attachment from the baffle surface. It can be observed that in systole, as expected, shear stresses
are high on the surface directly facing the right ventricle outlet and, due to mild detachment, wall
shear stresses on the far side drop to notably low values. Uneven contour distribution is due to the
bent present in the aortic arch, which strongly affects the velocity profile across the lumen. The
secondary wall shear stress peak observed in Figure 42, downstream of the baffle, is due to the
recirculation of the flow around the whole baffle surface.
Wall Shear Stress contour plot

Velocity contour plot

Figure 42 Comparison of velocity vs. wall shear stress during early systole (top) and early
diastole (bottom), with pressure measurement locations the same as in Figure 29.
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Figure 42 shows a comparison between wall shear stress and velocity to understand better
where and how a diastolic wall shear stress peak occurs posteriorly to the baffle. The peak can be
seen to match the locations where the flow reattaches to the surface, causing a localized rise in
wall shear stress. In magnitude, this peak is markedly smaller than the peaks observed in systole;
nevertheless, this cyclic peak may induce some fatigue stress on the underlying tissue, which
should not be ignored. To be noted once again is the uneven distribution of the wall shear stress
during diastole that can be attributed to the geometric irregularities present in this model. Uneven
stress distribution may have strong repercussions on how the epithelial tissue regenerates and heals
following the procedure.
Figure 44 focuses on the WSS distribution on the baffle surface on the systemic circulation
side across one heart cycle. As previously observed, the uneven distribution is ever-present. In
addition, the WSS peaks appear to periodically migrate, which leads to varying shear loads on the
baffle.
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Figure 43 Wall shear stress contour plot on the baffle surface in the systemic region (pressure
measurements locations the same as in Figure 34
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Energy Loss
Energy loss and energy efficiency were calculated and plotted first with respect to the flow split
ratio between the upper body and the lower body circulation and second with respect to the area
over the baffle. The nominal split ratio in this study was set to be 60/40 lower body / upper body
circulation based on the clinical data provided by Arnold Palmer Hospital. Moreover, energy loss
as a function of split ratio and area over the baffle were calculated, as shown in section 3.9.
The average energy loss due to the pressure drop and the viscous losses was found to be
12.53 ±1.39 mW for the split ratio study, and the average efficiency was found to be 0.91. For the
area over the baffle study, the average energy loss and the efficacy were found to be 12.47 ±0.18
mW and 0.91, respectively.

Increase

Decrease

Table 8 - Energy Loss and Energy Efficiency (E efficiency) as a function of the area over the
baffle
Case

PA
energy

DA
energy

EL
(mW)

E Efficiency

1

0.418

0.381

12.33

0.91

2

0.417

0.379

12.66

0.9

3

0.413

0.375

12.66

0.9

4

0.411

0.374

12.33

0.9

5

0.407

0.37

12.33

0.91

Table 8 offers a closer look at the effect of the baffle related narrowing on the energy loss, where
case 3 represents the nominal model.
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Table 9 - Energy Loss (EL) and Energy Efficiency (E efficiency) as a function of split ratio
DA
energy
0.307

EL
(mW)
10.33

E Efficiency

50/50

PA
energy
0.338

55/45

0.428

0.386

14

0.9

60/40

0.414

0.376

12.66

0.9

65/35

0.42

0.38

13.33

0.91

case

0.9

The energy loss as shown in Table 8, increased by about 3% (from 12.33 to 12.66) as the
descending aorta increases from case 1 to case 2 . However, no changes were examined in EL
between case 2 and case 3 (nominal). Moreover, the EL loss dropped in case 4 as the ascending
aorta increases and did not change in case 5, where the ascending aorta diameter was larger than
the nominal.
Furthermore, the energy loss for the 50/50 case exhibits the lowest energy loss value 10.3
mW, and then EL increased to 14 mW for the 55/45 split ratio as seen in Table 10 . Then starts
dropping as more blood flows to the lower body, 12.66 mW for the nominal 60/40 split ratio, and
13.33 mW for the 65/35 ratio.
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Figure 44 Energy loss versus area over the baffle

Figure 45 Energy loss versus split ratio
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Particle Residence Time
Particle residence time (PRT) represents the time required for a particle in the flow field to
exit any boundary. Areas with recirculation and flow stagnation can lead to a longer PRT, and that
indicates an increased risk of blood clotting. The coupled scheme was carried out first until a
converged solution was obtained and then the Lagrangian model was introduced by injecting
spherical particles randomly in space and time. We computed the PRT with different particle
diameters (2mm, 4mm, and 5mm) to quantify how long the particles take to exit the flow field and
flow circulation. A continuous release of particles throughout the cardiac cycle was set, and
particles were trace to calculate the average time plot was created to calculate the average time
particles take to travel from the injection point (MPA inlet) to the exit DA. Massless and material
particles were injected separately in this case. The massless particles follow the velocity vectors,
while the material particles might have some effects on the flow field. For the material particles,
the particle mass, gravity, buoyancy, drag, Saffman, and pressure gradient forces were considered
with 1116.73 (kg/m3) density. We carried out each simulation for several runs to measure the PRT
and to obtain a consistent solution. The results showed that, on average, particles take about less
than 0.5 (s) to exit the fluid domain. However, it also shows that some particles take longer to exit
(≥3 s). Moreover, as can be seen in Figure 47 contour, the peak PRT starts decreasing from 3.34 s
at the early systole then starts decreasing as the flow starts accelerating but then starts increasing
again at the late diastole. That could be due to the fact that some particles were stuck and then
were flushed by the high-pressure flow since we have a continuous particle injection, which could
be the reason for PRT increase at the end of diastole.
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Figure 46Particel Residence Time at different point of the cardiac cycle(Early systole,Peak
systole,Early diastole and Late diastole
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In Figure 47, we plotted the maximum, the minimum, and average PRT the particles take to exit
the flow field. The blue line represents the minimum PRT, which is almost (0 s), and then we have
the maximum time plot in green, which goes to (≥3 s). The take away from this plot is that on
average the particles clear the flow field in about (≥0.5 s).
For the material particles (2mm, 4 mm, and 5mm) models, we did not observe big
differences in the PRT calculations. The no change in PRT calculation could be because of two
reasons: (1) The short distance from the injection location to the exit and the fact the there is only
one exit for the particles, (2) we are calculating the average time of a higher number of particles
and even if some particles get stuck that would not affect the average PRT.

7

Average PRT
Max PRT
Min PRT

6

Particle Residence Time (s)

5

4

3

2

1

0
0

0.5

1

Physical Time (s)

Figure 47 Particle Residence Time (s) plot
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Oxygen Transport
The oxygen transport was reported as a function of the aortic root size, the area over the
baffle, and the flow split ratio between the upper body circulation and the lower body circulation.
The oxygen delivery and saturation were reported with different pulmonary vein saturation values
(100%, 95%, 90%, 85%, 80 %) depending on how healthy the pulmonary system of a patient
Table 10 Results for the Ascending aorta and area over the baffle studies (TotalSys:
Cardiac Output, DA: Descending Aorta)
Ascending Aorta Size Study

The Area Over The Baffle Study

case#

1

2

3

4

5

6

1

2

3

4

5

TotalSys(L/
min)
DA%

2.93

2.96

2.93

2.92

2.93

2.91

2.93

2.91

2.93

2.91

2.88

63.07

62.5

62.63

63.04

62.7

62.36

63.07

63.99

62.76

62.68

62.72

548.8

557.8

549.3

546.3

548.4

544.4

548.8

543.2

548.4

543.5

539.6

84.99

85.52

85.1

84.96

85.07

84.82

84.99

84.69

85.07

84.98

85.0

O2
delivery
Saturation

4.10.1 Effect of Ascending Aorta Diameter
The total cardiac output for the AO study was 2.93 ±0.02 (L/min) with a 60/40 split ratio
between the lower body and upper body circulation, as shown in Table 10. Moreover, it can be
seen that the changes in the AO diameter did not greatly affect the oxygen delivery compared to
the nominal model (case 4), where the standard deviation of the total systemic oxygenation s was
about ± 4.2 (average 549.17 l.min-1 .m-2). Table 10 offers a closer look at the effects of the AO
diameter on oxygen delivery and oxygen saturation, where 6 different aortic root configuration
were used. For full detailed results, see the appendix.
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Table 11 Total systemic flow rate in (Liter per minutes) as a function of Ascending Aorta size
and flow percentage of each boundary (TOTSYS: Total Cardiac Output,DA: Descending Aorta,
LcorA=Left Coronary Artery, RcorA=Right Coronary Artery, LCA=Left Caro
TOTSYS(l/min)

DA[%]

LCA[%]

LSA[%]

LcorA[%]

RCA[%]

RSA[%]

RcorA[%]

1

2.94

63.08

7.53

11.22

1.65

8.70

5.18

2.64

2

2.97

61.51

4.44

8.53

1.66

12.91

8.47

2.49

3

2.93

62.63

6.98

10.29

1.65

9.49

6.40

2.57

4

2.92

63.04

7.54

11.08

1.67

8.56

5.41

2.68

5

2.93

62.77

7.27

11.31

1.66

9.12

5.22

2.66

6

2.92

63.36

7.46

10.83

1.66

8.58

5.45

2.67

Figure 48 offers full detailed information about systemic saturation with different
pulmonary venous saturation as a function of aorta size

4.10.2 Effect of Area over the Baffle
As illustrated in section 3.1 and 4.4, different geometries were created by varying the MPA
narrowing sizes, measured as the minimum distance between the systemic baffle surface and the
distal pulmonary trunk surface. In section 4.4, we reported that all the MPA narrowing sizes in
that study did not cause pressure drops across the baffle above the clinically suggested threshold,
and all our geometries fell well within the acceptable range. In this study, we looked into the
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oxygen transport for the same synthetic geometries used in section 4.4 to quantify the effects the
MPA narrowing may impose on the oxygen delivery. In Table 13, we reported the cardiac output
and individual flow rates as a percentage of cardiac output with a 60/40 split ratio as a function of
the area over the baffle. The average oxygen delivery was (544.7 ± 3.5 ml.min-1 .m-2) and the
saturation about 84.95 as shown in Table 10.
Table 12 Total Systemic Flow Rate (Liter per minutes) as a Function of Area over the
Baffle and The Flow Percentage of Each Boundary (TOTSYS: Total Cardiac Output, DA:
Descending Aorta, LcorA=Left Coronary Artery, RcorA=Right Coronary Artery, LCA=Left
Carotid Artery, LSA=Left Subclavian Artery, RCA=Right Carotid Artery, RSA=Right
Subclavian Artery)
TOTSYS (L/min)

DA[%]

LCA[%]

LSA[%]

LcorA[%]

RCA[%]

RSA[%]

RcorA[%]

1

2.94

63.08

7.5

11.22

1.65

8.70

5.18

2.64

2

2.92

63.99

7.36

11.17

1.65

8.38

4.74

2.71

3

2.93

62.77

7.27

11.31

1.66

9.12

5.22

2.66

4

2.91

62.69

7.52

11.29

1.67

8.81

5.34

2.69

5

2.89

62.72

7.58

11.18

1.71

8.86

5.16

2.80

Figure 49 Full detailed information about systemic saturation with different pulmonary venous
saturation as a function of the area over the baffle
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4.10.3 Effect of the Split Ratio
In this study, we compare the systemic oxygen transport between the 60-40 and 50-50 split
ratio of the nominal MPA size and ±15%. The 50-50 did not hold the flow split after the solution
convergence, as can be seen in Table 15; it is more like 55-45.
Table 13 Oxygen transport and oxygen saturation comparison between 60-40 and 50-50 split
ratio for the nominal Case (TOTSYS: Total Cardiac Output, DA: Descending Aorta, PVO2:
Pulmonary Venous Flow Oxygen Saturation)
PULMONARY
VENOUS

OXYGEN RESULTS

SATURATION
Split ratio

TOTSYS(

Systemic Saturation

ml.min-1 )
100
95
90
85
80

50-50

578.64

91.3

60-40

580.58

90.07

50-50

546.95

86.3

60-40

548.35

85.1

50-50

515.27

81.3

60-40

516.12

80.1

50-50

483.58

76.3

60-40

483.89

75.07

50-50

451.9

71.3

60-40

451.66

70.07
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Figure 50 full detailed information about systemic saturation with different pulmonary venous
saturation as a function of the blood flow split ratio

Table 14 Total systemic flow rate (Liter per minutes) as a function split ratio and the flow
percentage of each boundary (TOTSYS: Total Cardiac Output, DA: Descending Aorta,
LcorA=Left Coronary Artery, RcorA=Right Coronary Artery, LCA=Left Carotid Artery,
LSA=Left Subclavian Artery, RCA=Right Carotid Artery, RSA=Right Subclavian Artery)
TOTSYS

DA%

LCA% LSA% LcorA%

RCA%

RSA% RcorA%

50-50

2.88

58.45

6.93

12.93

1.58

11.85

5.70

2.58

60-40

2.92

63.99

7.36

11.2

1.65

8.38

4.74

2.71

65-35

2.91

66.85

6.14

9.78

1.72

8.129

4.54
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2.59

CHAPTER FIVE: CONCLUSION
Conclusion
In this study, we have demonstrated a preliminary numerical analysis of a novel surgical
procedure for select newborns with single ventricle congenital heart disease. Using CFD
techniques, we investigated the flow in the systemic and pulmonary circulations in particular near
the baffle at the distal arch stenosis and near the T-junction of the SVC to the pulmonary arteries.
We display a viable model to investigate the HCS2 procedure critically.
In the first part of the analysis, we ensure that the mesh used for the unsteady calculation
would provide repeatable results. Similarly, under steady-state condition, we analyzed vortex
shedding from the baffle and determined that due to inadequate distances, vortices would be
dissipated at an early stage. Then we focused on geometrical features such as converging-diverging
nozzles that produce flow accelerations, hence large localized wall shear stress loads. This was
observed near the baffle. Large shear loads on the local tissue may cause damage. In both
circulations, there are two instances of flow impingement at the T-junction in the pulmonary
circulation and at the foreface of the baffle. Flow impinging on the surface generates high local
load concentrations, which, on a pulmonary artery, may cause vessel damage or even rupture and
on the baffle, may induce fatigue failure in the underlying stent. We will investigate these loading
conditions to ensure that over a prolonged period, the stent does not buckle as this would
compromise the pulmonary circulation. We will report the results of this study in the near future.
We isolated the baffle surface to further observe wall shear stress loads in relation to the
oscillatory nature of the unsteady flow. We have shown that throughout a cardiac cycle, the flow
detaches in systole and subsequently reattaches to the baffle surface. This induces very distinct
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wall shear distributions on the surface. In systole, wall shear stress magnitudes are rather elevated,
and in diastole, we observe uneven wall shear stress distribution, which can alter the mechanical
and chemical properties of the local tissue. It must be noted that due to the complex topology,
irregular flow patterns such as recirculation regions and strong secondary flows are generated.
Given the current model, there is an opportunity to computationally explore, via shape
optimization, topological improvement of the HCS2. Moreover, loading conditions on the stent
obtained from these computations can serve as input to the mechanical analysis of the stented
baffle.
The effect of incremental flow obstruction due to the baffle was also investigated to ensure
that the model did not include MPA narrowing sizes that caused pressure drops across the baffle
above the clinically suggested threshold. We concluded that our geometries fell well within the
acceptable range.
The average particle residence time was about 0.5 (s) which is equal to the same period
each heart cycle takes. The peak time was also reported and the results show that some particles
might take up to (3 s) to exit the fluid domain. Finally, the energy loss and energy efficiency were
calculated as a function of split ratio and baffle related narrowing. Across all models, the efficiency
was shown to be high.
The systemic oxygen transport model was derived based on conservation of mass and
oxygen uptake and consumption. Three geometric parameters were modified while calculating
oxygen saturation: (1) The aortic root size, (2) The baffle related narrowing and (3) the flow split
ratio. The saturation results showed consistency with published Glenn procedure data and the
change in the ascending aorta size did not have a great impact on the oxygen transport.
97

Limitations
The first limitation of this stud is the rigid vessel wall assumption for all the models in this study.
However, a study by [181] found a little effect of implementing fluid-structure interaction (FSI)
on pressure and energy efficiency . For the particle residence time study, we assumed massless
particles that passively convected by the converged fluid domain. The adhesion between the
particles and the walls were neglected .We also did not look at how long particles spend at certain
location since we are looking for the total accumulative time. The discrete method used in this
study to measure PRT is mesh indecency which means that the calculated time highly dependent
on the orientation of the cells.
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APPENDIX A: FULL LPM EQUATIONS

100

Current Auxiliary Equations

𝑖𝑖1 =
𝑖𝑖2 =
𝑖𝑖1 =

𝐼𝐼𝑖𝑖𝑖𝑖 (𝑦𝑦) =
𝑤𝑤ℎ𝑒𝑒𝑒𝑒𝑒𝑒

𝑦𝑦1 − 𝑦𝑦2
∗ ℎ𝑒𝑒𝑒𝑒(𝑦𝑦1 , 𝑦𝑦2 )
𝑅𝑅𝑡𝑡𝑡𝑡𝑡𝑡

𝑦𝑦2 − 𝑦𝑦3
∗ ℎ𝑒𝑒𝑒𝑒(𝑦𝑦2 , 𝑦𝑦3 )
𝑅𝑅𝑟𝑟𝑟𝑟

𝑦𝑦3 − 𝑦𝑦34
∗ ℎ𝑒𝑒𝑒𝑒(𝑦𝑦3 , 𝑦𝑦34 )
𝑅𝑅𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

𝑦𝑦21 − 𝑦𝑦1 𝑦𝑦24 − 𝑦𝑦1 𝑦𝑦30 − 𝑦𝑦1 𝑦𝑦31 − 𝑦𝑦1
+
+
+
𝑅𝑅𝑖𝑖𝑖𝑖𝑖𝑖
𝑅𝑅𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

1 𝑖𝑖𝑖𝑖 𝑥𝑥1 − 𝑥𝑥2 > 0
ℎ𝑒𝑒𝑒𝑒(𝑥𝑥1, 𝑥𝑥2) = �
𝑖𝑖𝑖𝑖 𝑎𝑎 ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
0 𝑖𝑖𝑖𝑖 𝑥𝑥1 − 𝑥𝑥2 ≤ 0
Voltage Auxiliary Equations
𝑣𝑣1 (𝑦𝑦) = 𝑅𝑅𝑑𝑑𝑑𝑑 (𝑦𝑦4 − 𝑦𝑦7) + 𝑦𝑦5

𝑣𝑣2 (𝑦𝑦) = 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙 (𝑦𝑦7 + 𝑦𝑦10) + 𝑦𝑦8

𝑣𝑣3 (𝑦𝑦) = 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙 (𝑦𝑦13 − 𝑦𝑦10) + 𝑦𝑦11
𝑣𝑣5 (𝑦𝑦) =

𝑦𝑦14
𝑦𝑦
+ 16 �
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙
1
1
+
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟 𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟

𝑦𝑦18 − 𝑦𝑦13 + �

𝑣𝑣4 (𝑦𝑦) = 𝑅𝑅𝑖𝑖𝑖𝑖 (𝑦𝑦18 − 𝑦𝑦13) + 𝑣𝑣5(𝑦𝑦)
𝑣𝑣6 (𝑦𝑦) =

𝑦𝑦19
𝑦𝑦
𝑦𝑦3
+ 20 +
�
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙 𝑅𝑅𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎
1
1
1
+
+
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙 𝑅𝑅𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

𝑦𝑦18 + �
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Circuit ODEs

𝑦𝑦(1) =
𝑦𝑦(2) =

1

𝐶𝐶𝑟𝑟𝑟𝑟(𝑡𝑡)

1
(𝐼𝐼 (𝑦𝑦) − 𝑖𝑖1 (𝑦𝑦)
𝐶𝐶𝑟𝑟𝑟𝑟 𝑖𝑖𝑖𝑖

(𝑖𝑖1 (𝑦𝑦) − 𝑖𝑖2 (𝑦𝑦) ∗ 𝑑𝑑𝑑𝑑𝑟𝑟𝑟𝑟(𝑡𝑡) (𝑦𝑦) − 𝑖𝑖3 (𝑦𝑦)

𝑦𝑦(3) =

𝑦𝑦(4) =

𝑦𝑦(7) =

1

1

𝐶𝐶𝐼𝐼𝐼𝐼𝐼𝐼

1

𝐿𝐿𝐼𝐼𝐼𝐼𝐼𝐼

𝐿𝐿𝐼𝐼𝐼𝐼𝐼𝐼_𝑙𝑙𝑙𝑙𝑙𝑙
𝑦𝑦(8) =

𝑦𝑦(9) =
𝑦𝑦(10) =

1

(𝑦𝑦5 − 𝑦𝑦6 ∗ 𝑅𝑅𝐼𝐼𝐼𝐼𝐼𝐼 − 𝑦𝑦21)

1 𝑣𝑣2(𝑦𝑦) − 𝑦𝑦8
(
− 𝑦𝑦9 )
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙
𝐶𝐶𝐼𝐼𝐼𝐼𝐼𝐼

𝐿𝐿𝐼𝐼𝐼𝐼𝐼𝐼

𝑦𝑦(11) =

𝑣𝑣1(𝑦𝑦) − 𝑦𝑦5
− 𝑦𝑦6 )
𝑅𝑅𝑑𝑑𝑑𝑑

(

(𝑣𝑣1(𝑦𝑦) − 𝑦𝑦7 ∗ 𝑅𝑅𝑑𝑑𝑑𝑑_𝑙𝑙𝑙𝑙𝑙𝑙 − 𝑣𝑣2(𝑦𝑦)

1

𝐿𝐿𝑙𝑙𝑙𝑙𝑙𝑙_𝑖𝑖𝑖𝑖𝑖𝑖

𝑦𝑦(12) =

(𝑖𝑖2 (𝑦𝑦) − 𝑦𝑦4 )

1
(𝑦𝑦 − 𝑦𝑦4 ∗ 𝑅𝑅𝑝𝑝𝑝𝑝 − 𝑣𝑣1(𝑦𝑦)
𝐿𝐿𝑝𝑝𝑝𝑝 3

𝑦𝑦(5) =
𝑦𝑦(6) =

1

𝐶𝐶𝑝𝑝𝑝𝑝

(𝑦𝑦8 − 𝑦𝑦9 ∗ 𝑅𝑅𝐼𝐼𝐼𝐼𝐼𝐼 − 𝑦𝑦22)

(𝑣𝑣3(𝑦𝑦) − 𝑦𝑦10 ∗ 𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙_𝑙𝑙𝑙𝑙𝑙𝑙 − 𝑣𝑣2(𝑦𝑦)
1 𝑣𝑣3(𝑦𝑦) − 𝑦𝑦11
(
− 𝑦𝑦12 )
𝐶𝐶𝐼𝐼𝐼𝐼𝐼𝐼
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙

1

𝐿𝐿𝐼𝐼𝐼𝐼𝐼𝐼

(𝑦𝑦11 − 𝑦𝑦12 ∗ 𝑅𝑅𝐼𝐼𝐼𝐼𝐼𝐼 − 𝑦𝑦23)
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𝑦𝑦(13) =

1

𝐿𝐿𝑙𝑙𝑙𝑙𝑎𝑎𝑖𝑖𝑖𝑖

𝑦𝑦(14) =
𝑦𝑦(15) =

𝑦𝑦(18) =

1 𝑣𝑣5(𝑦𝑦) − 𝑦𝑦14
(
− 𝑦𝑦15 )
𝐶𝐶𝑟𝑟𝑟𝑟𝑟𝑟
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟

1

1

𝐶𝐶𝑟𝑟𝑟𝑟𝑟𝑟

1

𝐿𝐿𝑖𝑖𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

𝑦𝑦(20) =

(𝑦𝑦34 − 𝑦𝑦18 ∗ 𝑅𝑅𝑖𝑖𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 − 𝑣𝑣4(𝑦𝑦))

1

𝐶𝐶𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟
1

𝐶𝐶𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙

𝑦𝑦(21) =
𝑦𝑦(22) =
𝑦𝑦(23) =
𝑦𝑦(24) =

1

𝐶𝐶𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

1

𝑦𝑦34 − 𝑦𝑦19 𝑦𝑦19 − 𝑦𝑦24
−
)
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

(

𝑦𝑦34 − 𝑦𝑦20 𝑦𝑦20 − 𝑦𝑦24
−
)
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙

(

1
𝑦𝑦21 − 𝑦𝑦1
(𝑦𝑦6 −
)
𝐶𝐶𝑖𝑖𝑖𝑖𝑖𝑖
𝑅𝑅𝑖𝑖𝑖𝑖𝑖𝑖

𝐶𝐶𝑑𝑑𝑑𝑑𝑑𝑑
1

𝑣𝑣5(𝑦𝑦) − 𝑦𝑦16
− 𝑦𝑦17 )
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟

(

(𝑦𝑦16 − 𝑦𝑦17 ∗ 𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟 − 𝑦𝑦23)

𝐿𝐿𝑟𝑟𝑟𝑟𝑟𝑟

1

𝑦𝑦(19) =

(𝑦𝑦14 − 𝑦𝑦15 ∗ 𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟 − 𝑦𝑦22)

𝐿𝐿𝑟𝑟𝑟𝑟𝑟𝑟

𝑦𝑦(16) =
𝑦𝑦(17) =

(𝑣𝑣4(𝑦𝑦) − 𝑦𝑦13 ∗ 𝑅𝑅𝑙𝑙𝑙𝑙𝑎𝑎𝑖𝑖𝑖𝑖 − 𝑣𝑣3(𝑦𝑦)

𝐶𝐶𝑑𝑑𝑑𝑑𝑑𝑑

(𝑦𝑦15 + 𝑦𝑦9 −
(𝑦𝑦12 + 𝑦𝑦17 −

𝑦𝑦22 − 𝑦𝑦32
)
𝑅𝑅𝑑𝑑𝑑𝑑𝑑𝑑

𝑦𝑦23 − 𝑦𝑦32
)
𝑅𝑅𝑑𝑑𝑑𝑑𝑑𝑑

𝑦𝑦19 − 𝑦𝑦24 𝑦𝑦20 − 𝑦𝑦24 𝑦𝑦24 − 𝑦𝑦1
+
−
)
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑅𝑅𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

(
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1

𝑦𝑦(25) =
𝑦𝑦(26) =
𝑦𝑦(27) =

𝐶𝐶𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

1

𝐿𝐿𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟
1

𝐿𝐿𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏

(𝑦𝑦25 − 𝑦𝑦26 ∗ 𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 − 𝑦𝑦31 )

(𝑣𝑣7(𝑦𝑦) − 𝑦𝑦27 ∗ 𝑅𝑅𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 − 𝑦𝑦28 )

𝑦𝑦(28) =
𝑦𝑦(29) =

1

𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿

𝑦𝑦(30) =

𝑦𝑦(32) =
𝑦𝑦(33) =
𝑦𝑦(34) =

1

𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

1

𝐶𝐶𝑠𝑠𝑠𝑠𝑠𝑠

1

1

𝐶𝐶𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿

1

𝐶𝐶𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝐶𝐶𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

(

𝐿𝐿𝑠𝑠𝑠𝑠𝑠𝑠

(𝑦𝑦27 − 𝑦𝑦29 )

(𝑦𝑦28 − 𝑦𝑦29 ∗ 𝑅𝑅𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 − 𝑦𝑦30 )

1

𝑦𝑦(31) =

𝑣𝑣7(𝑦𝑦) − 𝑦𝑦25
− 𝑦𝑦26 )
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟

(

(𝑦𝑦29 −
(𝑦𝑦26 −

𝑦𝑦22 −𝑦𝑦32
𝑅𝑅𝑑𝑑𝑑𝑑𝑑𝑑

+

𝑦𝑦31 − 𝑦𝑦1
)
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

𝑦𝑦23 −𝑦𝑦32
𝑅𝑅𝑑𝑑𝑑𝑑𝑑𝑑

− 𝑦𝑦33 ))

(𝑦𝑦32 − 𝑦𝑦33 ∗ 𝑅𝑅𝑠𝑠𝑠𝑠𝑠𝑠 − 𝑣𝑣7(𝑦𝑦))

(𝑖𝑖3 (𝑦𝑦) − 𝑦𝑦18 −

𝑤𝑤ℎ𝑒𝑒𝑒𝑒𝑒𝑒 𝑑𝑑𝑑𝑑(𝑡𝑡) =

𝑦𝑦30 − 𝑦𝑦1
)
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙

𝑦𝑦34 − 𝑦𝑦20 𝑦𝑦34 − 𝑦𝑦19
−
)
𝑅𝑅𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑅𝑅𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟

𝐶𝐶(𝑡𝑡 + ∆𝑡𝑡) − 𝐶𝐶(𝑡𝑡)
𝑎𝑎𝑎𝑎𝑎𝑎 ∆𝑡𝑡 = 10−6
∆𝑡𝑡
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